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During nervous system development, progenitor cells multiply under the control 
of the cell cycle pathway. When they are poised to differentiate, they withdraw from the 
cell cycle to form appropriate neuronal cell types. Cell cycle regulation is therefore 
closely intertwined with progenitor proliferation and neurogenesis in the developing 
nervous system and often, common factors and pathways are utilized in these processes. 
Two properties of neuronal progenitors can be critical for proper nervous system 
development: the time they take to complete one cell cycle, and the exact timing of their 
withdrawal/exit from the cell cycle to form neurons. Understanding how these properties 
can be manipulated to influence progenitor cell proliferation and neurogenesis can be 
invaluable for devising therapeutic strategies involving neuronal stem/progenitor cells. 
Retina, the primary tissue for vision, is an excellent model system for studying nervous 
system development and neuronal progenitor cell biology. To gain potential insights into 
the issues described above, this dissertation focuses on the role of the cell cycle 
regulators the D-cyclins, Cyclin D1 (Ccnd1) and Cyclin D3 (Ccnd3), during retinal 
development and characterizes the retinal phenotypes of Ccnd1 and Ccnd3 knockout 
mice. 
Chapter 1 is an introduction to retinal development and sets up the relevant 
questions addressed here. 
Chapter 2 is a reprint of a published journal article titled, “Cyclin D1 fine-tunes 
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the neurogenic output of embryonic retinal progenitor cells.” The study shows that during 
mouse embryonic development, CCND1 expression in retinal progenitor cells (RPCs) is 
critical for maintenance of their cell cycle time and also for their timing of exit from the 
cell cycle. Further, CCND1 ensures that the correct complements of early-born retinal 
neurons are generated from progenitors. 
Chapter 3 deals with the role of D-cyclins during postnatal retina development. 
The study shows that CCND1 also influences the production rate of late-born retinal cell 
types. Unexpectedly, although Ccnd1 null retinas experience progenitor cell depletion 
during development, proliferation, and neurogenesis persist well beyond the normal 
period of retinal histogenesis in mutant retinas. Further, Ccnd3 is unable to compensate 
for Ccnd1's role in regulation of cell cycle time and cell cycle withdrawal. 
Chapter 4 discusses the implications and relevance of the above studies. Future 
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This chapter is a primer on retina development from a cell biological perspective. 
It begins with a short introduction to retinal histogenesis. Subsequently, relevant 
properties of retinal cell types are discussed. Proliferation of progenitor cells in the retina 
and differentiation of retinal neurons from these progenitors is intricately associated with 
the cell cycle pathway. The time a progenitor takes to complete one cell cycle and the 
timing of its withdrawal/exit from the cell cycle are both critical factors for proper 
development of retinal form and function. Cell cycle regulators play a prominent role in 
retinal development. D-type cyclins are positive regulators of cell cycle progression. 
CyclinD1 (Ccnd1) is highly expressed in all retinal progenitors, but Cyclin D3 (Ccnd3) is 
normally expressed in glial cells of the retina. Towards the end of this chapter, a rationale 
for studying the role of CCND1 and CCND3 during retinal histogenesis is presented.  
 
 
Overview of retina development 
The basic pattern of vertebrate ocular and retinal development, outlined in Fig. 
1.1, is conserved across species (Chow and Lang, 2001; Gehring, 2004; Lamb et al., 
2007). Eye formation begins when a population of cells in the anterior neural plate, later 
to be the forebrain, is specified as the eye field (Fig. 1.1A). With the neural plate growing 
upward and inwards towards the midline (Fig. 1.1B), the optic grooves, derived from the 
eye field, evaginate towards the surface ectoderm (Fig. 1.1C and D). With the progress of 
development, the lips of the neural fold meet at the midline and pinch off from the 
surface ectoderm to form the neural tube (Fig. 1.1E). In addition, by this time, the optic 
grooves are in close contact with the non-neural surface ectoderm and form the optic 
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vesicles (Fig. 1.1 E). Signaling and patterning events at this stage begin to demarcate the 
presumptive neural retina, retinal-pigmented epithelium (RPE), and optic stalk domains 
(Yang, 2004). Interaction between the optic vesicle and the surface ectoderm induces the 
former to invaginate and the latter to differentiate into the lens placode (Fig. 1.1E). 
Invagination of the optic vesicle forms the optic cup structure, which consists of both the 
retina and the RPE in close apposition (Fig. 1.1F). At this stage, the progenitor cells in 
the retina domain have a greater rate of proliferation than RPE progenitors, making the 
retina much thicker than the single layered RPE (Bharti et al., 2006). The optic cups stay 
connected to the forebrain through the optic stalks (Fig. 1.1F). The lens placode also 
starts to proliferate and invaginate during this time; soon, it will pinch off from the 
surface ectoderm and form the lens (Fig. 1.1G). The optic cup eventually grows 
circumferentially to enclose the choroid fissure and neurogenesis initiates in the central 
optic cup, producing ganglion cells, whose axons form the optic nerve (Fig. 1.1G). This 
begins retinal histogenesis, a period of intense progenitor proliferation and the 
simultaneous production of all retinal cell classes (Agathocleous and Harris, 2009; 
Livesey, R. and Cepko, C., 2001).  
 
 
Retinal cell types 
Retinal progenitor cells (RPCs) 
Restricted potential  
Dividing neuronal progenitor cells that populate the retina from its specification 
up to the termination of its histogenesis can be called retinal progenitor cells (RPCs). All 
cell types in the retina ultimately arise from the RPCs. Unlike pluripotent stem cells 
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RPCs are more restricted in their potential. They are capable of producing only retinal 
neurons. Therefore, both embryonic stem cells (ES) and induced pluripotent stem cells 
(iPS) are capable of generating RPCs and retinal neurons. To do so, they require specific 
growth factor/small molecule treatment or misexpression of the so-called 'eye field 
transcription factors' (EFTFs) (Dong et al., 2003; Ikeda et al., 2005; Lamba et al., 2006; 
Lamba et al., 2010; Osakada et al., 2009a; Osakada et al., 2009b; Osakada et al., 2008; 
Viczian et al., 2009; Zuber et al., 2003).  
 
 
Pre-neurogenic versus neurogenic RPCs  
Up to a certain point in retinal development, RPC are 'pre-neurogenic', in that they 
undergo division to produce only proliferating daughter RPCs (exponential division). 
Subsequently, RPCs are ‘neurogenic’ and become capable of producing immature 
neuronal precursor cells (precursors) that withdraw/exit from the cell cycle. The initiation 
of neurogenesis from neurogenic RPCs begins in the central optic cup (McCabe et al., 
1999; Prada et al., 1991; Reese and Colello, 1992). Subsequently, a wave of neurogenesis 
spreads out towards the peripheral retinal regions. Recent studies in the chicken retina 
revealed distinct patterns of gene expression that distinguish between pre-neurogenic and 
neurogenic RPCs. Pre-neurogenic RPCs express the transcription factor PAX6 and the 
notch receptor pathway ligand DELTA1. As these RPCs transition to a neurogenic state, 
they decrease PAX6 expression, extinguish DELTA1 expression, and begin to express 
E2A, a known binding partner for pro-neural BHLH factors (see below) (Hsieh and Yang, 
2009; Yang et al., 2009). The DELTA1 to E2A switch happens en masse in a group of 
neighboring RPCs and leads the outward-spreading wave of neurogenesis (Yang et al., 
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2009). In regions through which the neurogenesis wave has passed, RPCs divide to 
produce either two daughter RPCs, a combination of an RPC and a precursor or two 
precursor cells. As retinal development progresses, the frequency of RPC-producing 
divisions decreases and neuron-producing divisions increases. Eventually, when the 
balance shifts to exclusively precursor-producing terminal divisions, retinal histogenesis 
terminates (Livesey, F. J. and Cepko, C. L., 2001). This dynamic pattern of progenitor 
cell division is also seen in other parts of the developing nervous system including the 
developing cortex (Chenn and McConnell, 1995). 
 
 
Diversity in RPC expression profile  
Being either pre-neurogenic or neurogenic is not the only parameter of variability 
amongst RPCs. RNA expression profiling of mouse RPCs at various stages of 
development revealed great diversity amongst these cells, even when they were isolated 
from the same stage of development (Trimarchi et al., 2008). Dynamic expression of 
transcription factors in RPCs accounted for a major part of this diversity (Trimarchi et al., 
2008). Expression differences amongst multipotent RPCs point towards diversity in their 
intrinsic identity, capacity to respond to their environment, and competence to produce 
different precursor cell types over their developmental history. 
 
 
Temporal changes in RPC competence 
Several lines of evidence support the idea that RPCs change their 'competence' 
over developmental time. Competence is defined as the ability of an RPC to respond to 
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its environment and make certain types of precursors or acquire a strong bias towards 
making these precursors. 
It was observed that precursor cell types were produced from RPCs in an 
evolutionarily conserved temporal sequence (Young, 1985a; Young, 1985b). Further, 
when 'early' RPCs were co-cultured with 'late' RPCs, or were transplanted into a 
developmentally advanced retina, they still generated the early-born cell types that they 
normally would in spite of being in a 'late' environment. Conversely, when late RPCs 
were co-cultured with excess of early RPCs, they did not generate early-born cell types 
(Belliveau and Cepko, 1999; Belliveau et al., 2000; Rapaport et al., 2001; Watanabe and 
Raff, 1990). This suggests that RPCs have intrinsic 'competence states' that undergo 
unidirectional changes over time. Such competence stages were also observed in the 
developing cortex (Desai and McConnell, 2000). The competence model was nicely 
demonstrated in Drosophila neuroblasts (NBs), where transient and sequential expression 
of the four transcription factors Hunchback (Hb), Krüppel (Kr), Pdm, and Castor 
conferred temporal competence upon NBs to produce a conserved order of distinct 
progeny neurons. These factors retained their expression in the neurons produced from 
NBs during their expression period (Isshiki et al., 2001). Factors like HB, KR, PDM, and 
CASTOR were both necessary and sufficient for production of the cell types that retained 
the expression of these factors (Grosskortenhaus et al., 2006; Isshiki et al., 2001; Pearson 
and Doe, 2003). Thus, when HB or KR was overexpressed, they induced NBs to produce 
more of the cell types that express these factors, at the expense of the later-born cell types. 
Conversely, when HB or KR was removed, the NBs skipped the production of the earlier-
born cell types that expressed factors but produced later-born cell types (Isshiki et al., 
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2001; Livesey, R. and Cepko, C., 2001). However, mere expression of these factors was 
not always enough to induce NBs to produce neurons that retained their expression. 
Although misexpression of HB in older NBs was sufficient to induce production of early-
born cell types, this ability declined with increasing age of the NBs (Pearson and Doe, 
2003).  
Recent studies have lent more credence to this model in the mouse retina. 
Expression of IKAROS (IK), the mouse ortholog of HB, was seen in early embryonic 
RPCs, but its expression faded from late postnatal RPCs, many of which were derived 
from IKAROS-expressing RPCs (Elliott et al., 2008). IKAROS expression was also 
observed exclusively in early-born retinal ganglion, horizontal, and amacrine cells. In Ik-/- 
mice, production of the above-mentioned cell types were significantly reduced, not 
eliminated, but production of late-born cell types was normal. Forced expression of Ik in 
later stage retinas (postnatal day one mice), significantly increased the expression of 
horizontal and amacrine cells. Ik misexpression did not induce the production of ganglion 
cell, the earliest born retinal cells, in vivo. However, Ik misexpression did induce 
ganglion cell production from RPCs in low-density cultures of late retinal cells (Elliot 
2008). Interestingly, loss of IKAROS expression was required for production of Müller 
glia cells and misexpression of IKAROS prevented glial cell formation. 
In another study, conditional deletion of the RNAse III enzyme Dicer in the 
mouse retina, important for microRNA (miRNA) maturation, extended the period of 
ganglion cell genesis well beyond birth (Georgi and Reh, 2010). Further, differentiation 
of late-born cell types like glia or bipolar cells was severely impaired in retinal areas 
lacking Dicer. This indicates that Dicer activity or specific miRNAs are required by 
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RPCs to progress from an early ganglion cell producing competence state to late-born 
cell type producing competence state (Georgi and Reh, 2010). Incidentally, most cell 
types except ganglion cells failed to survive in mature Dicer deficient retinas, underlining 
the extensive requirement for DICER in retinal development and function. 
The above studies highlight the importance of both intrinsic state and external 
environment in defining competence. For testing whether a factor truly induces a 
competence state for production of certain cell types, misexpression of the factor is not 
adequate. The misexpressing cells must be placed in a permissive environment for true 
test of a competence state and a competence-inducing factor. 
 
 
Retinal neuronal precursors and neurons  
Defined order of cell type genesis  
If a progeny cell of an RPC division is fated to become a neuron, it exits or withdraws 
from the cell cycle pathway to form an immature precursor cell. The time of exit of a 
precursor from the cell cycle is the 'birth date' of that cell. With the progress of retinal 
development, precursor cells express markers of maturation appropriate to their particular 
neuronal lineage. Subsequently, they migrate to their appropriate laminar location in the 
retina and integrate into the emerging visual circuit. Retinal precursors are 'born' in a 
defined but overlapping order (La Vail et al., 1991; Rapaport et al., 2004; Wong and 
Rapaport, 2009). In general, the less abundant cell types are born earlier and the more 
abundant cell types are born later during retinal development (Farah and Easter, 2005; 
Finlay, 2008; Jeon et al., 1998). Thus, retinal ganglion cells (RGCs) are the first cell 
types to be born, followed closely, in an overlapping manner, by horizontal cells and 
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cone photoreceptor cells. Amacrine and rod photoreceptor cell production follows, with 
the genesis period of the rod cells, the most abundant cell type in the murine retina (Jeon 
et al., 1998), straddling both embryonic and postnatal stages. Finally, the last cell types to 
be generated are the bipolar neurons and Müller glia cells. This order of neuronal cell 
production is highly conserved amongst various species. The only known subtle 
exception to this temporal sequence is rod photoreceptor cell generation. Nocturnal 
animals have relatively more rods for facilitating low light vision. The peak of rod 
photoreceptor production in these animals moves towards later development. This has 
been proposed to be part of an evolutionary strategy, where the ‘envelope’ of cell cycle 
exit, and the production of more abundant cell types, is shifted towards later development 
(Dyer et al., 2009; Finlay, 2008). Therefore, in Xenopus, rod generation closely follows 
cone generation (Wong and Rapaport, 2009). However, in the nocturnal mouse retina, the 
period of rod genesis is pushed more toward the end of retinal histogenesis, away from 
cone genesis. Temporal orders of birth also exist among subclasses of cells within a 
major class. For example, cone bipolar cells are born before rod bipolar cells, 
GABAergic amacrine cells are produced ahead of glycinergic amacrine cells, and axon-
bearing horizontal cells are born before axon-less horizontal cells in chick (Cherry et al., 
2009; Edqvist et al., 2008; Morrow et al., 2008; Voinescu et al., 2009).  
 
 
The cell cycle 
Overview  
The cell cycle is the one-way molecular pathway through which a progenitor 
undergoes cell division. In course of the cell cycle, a progenitor cell doubles its diploid 
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genomic content, and during mitosis, its DNA is equally distributed between daughter 
cells. In somatic tissues, the cell cycle is also associated with cellular growth (Levine, 
2004), and besides duplicating and dividing its genome, a dividing cell also undertakes 
'cytokinesis', whereby it distributes its cytoplasm amongst its daughter cells.  
The most common somatic cell cycle, coupled to growth and occurring in the 
developing retina, has four major phases (G1, S, G2, and M). It also has major 
'checkpoints' to prevent erroneous cell cycle progression and a ‘restriction-point’ towards 
the end of G1 beyond which an RPC is irreversibly committed to cell division (Hartwell 
and Weinert, 1989; Kastan and Bartek, 2004; Pardee, 1974). Progression through the cell 
cycle is mainly ensured by the Cyclin and Cyclin dependent Kinase family (CDK) of 
proteins (Malumbres and Barbacid, 2009). Cyclin dependent kinase inhibitors (CDKIs) 
are negative regulators of cell cycle progression that provide balance to the process 
(Sherr and Roberts, 1999).   
 
 
Cell cycle time and neurogenic output 
It is intuitive to comprehend that the time an RPC takes to go around one 
complete cell cycle can affect the overall cell number of a tissue. A faster cell cycle may 
lead to increased proliferation and growth. A slower cell cycle can result in a tissue with 
low cell number. Usually as development progresses, the average cell cycle time of the 
RPC population increases (Alexiades and Cepko, 1996). This correlates with an increase 
in precursor producing cell divisions and a decrease in progenitor producing divisions. As 
we shall see in subsequent chapters, a change in cell cycle time regulation can result in 
 11 
altered proliferation, lower total cell number, and perhaps even an altered period of 
retinal histogenesis (Chapters 2 and 3). 
The rate and timing of cell cycle exit of the RPC population during development 
can be critical for proper growth and the final size of a tissue. In a developing tissue, cell 
cycle exit is the primary process that initially apportions precursor cells to each cell class. 
At any given point during retinal development, the rate of precursor generation from 
RPCs by virtue of cell cycle exit can be defined as the neurogenic output of RPCs. 
Neurogenic output, or the rate of cell cycle exit, is amenable to direct measurement by 
simple assays. 
Historically, neurogenic output is similar to measurements of the quiescent (Q) 
fraction, which is the fraction of progenitor cells exiting the cell cycle during a single cell 
cycle (Takahashi et al., 1996; Takahashi et al., 1997). The complementary measurement 
is the proliferative (P = 1-Q) fraction, which is the fraction of progenitors that continue to 
proliferate. Chapters 2 and 3 of this dissertation will highlight instances where cell cycle 




Cell cycle phases 
Gap 1 (G1) phase: cell cycle progression versus cell cycle exit  
The G1 phase or the first 'gap' phase is so termed because it is considered a gap 
between the mitosis (M) and the DNA synthesis (S) phase. This phase of the cell cycle is 
critical during the development of a tissue because a progenitor cell makes the decision 
either to remain in the cell cycle or to withdraw from the cell cycle at G1. To stay in the 
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cell cycle, a progenitor cell has to pass the 'restriction point', near the end of the G1 phase 
of the cell cycle (Blagosklonny and Pardee, 2002). Once past this point, a progenitor 
enters the DNA synthesis phase and is almost sure to complete cell division.  
The molecular pathway that is central to regulation of G1 phase progression or 
withdrawal from the cell cycle is the retinoblastoma (RB) pathway (Sun et al., 2007). The 
retinoblastoma protein family (Rb1, Rbl1/p107, and Rbl2/p130) is important for 
regulation of G1 progression, cell cycle exit, and maintenance of the precursor state after 
cell cycle exit. Active or under-phosphorylated forms of RB proteins prevent a progenitor 
from progressing past the restriction point and seem to keep exited cells from re-entering 
the cell cycle. Deletion of RB in the retina results in ectopic proliferation of neuronal 
precursor cells (Chen et al., 2004; Dyer and Bremner, 2005; Zhang et al., 2004). This is 
strikingly demonstrated in the 'single copy p107' retina, where only a single genomic 
copy of the p107 gene is expressed in the retina. Horizontal cells in the retina of these 
animals re-enter the cell cycle and proliferate prodigiously. However, at the same time, 
they retain characteristics of mature horizontal cells (Ajioka et al., 2007). Therefore, Rb 
family members are critical for connecting cell cycle state with cellular differentiation 
state, so that neuronal maturation only occurs in cells that have exited the cell cycle. 
D and E type cyclins are G1 phase specific (Sherr, 1993). Activity of D-cyclins is 
required in early G1 phase. They bind to and partner with CDK4/6 to perform two 
important functions that lead to phosphorylation and thus inactivation of RB proteins. 
Firstly, they directly phosphorylate RB proteins through the kinase activity of CDKs. 
Secondly, they sequester P27KIP1, an inhibitor of Cyclin E-CDK2 complex, and enable 
the complex to further phosphorylate retinoblastoma proteins at a different site (Kozar 
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and Sicinski, 2005; Levine and Green, 2004; Musgrove, 2006). Cyclin E expression is 
itself repressed by RB proteins through their inhibitory effect on E2F transcription factors 
(Chen, H. Z. et al., 2009; Sherr, 1995a). Thus, activation of Cyclin E-CDK2 complex 
initiates a positive feedback loop that leads to full activation of Cyclin E. The 
phosphorylation-mediated inactivation of RB proteins ultimately leads to overcoming the 
restriction point. E2Fs are instrumental downstream of RB proteins in this process and 
promotes entry into S-phase by activating targets like Cyclin E, Cyclin A, and DNA 
polymerases for DNA replication (Lundberg and Weinberg, 1998; Sherr, 1993; Sherr and 
Roberts, 1999). 
Given that the retinoblastoma pathway is central to the regulation of cell cycle 
progression versus exit, CDK inhibitors that keep RB proteins in an active state tend to 
promote cell cycle exit. Loss of p27Kip1, p57Kip2, and p19Ink4d, the three CDKIs 
expressed in the retina, leads to ectopic proliferation (Dyer and Cepko, 2000a; Dyer and 
Cepko, 2001; Levine and Green, 2004; Levine et al., 2000). Interestingly, combined 
deletion of p27Kip1 and p19Ink4d led to synergistic increase in ectopic proliferation and 
cell cycle re-entry of horizontal and amacrine cells (Cunningham et al., 2002).  
 
 
DNA synthesis (S) phase  
A progenitor cell doubles its 2N DNA content to 4N through DNA replication in 
the S phase. DNA replication is initiated at multiple replication origin points in the 
genome and the action of replication complexes that include DNA helicases and 
polymerases ensure duplication of the genome. Cyclin A-Cdk2 complex promotes S-
phase progression by activating existing replication complexes (Coverley et al., 2002). It 
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also inhibits assembly of new replication complexes during the same period, ensuring 
that origins do not fire again until the next S phase (Coverley et al., 2002; Machida et al., 
2005). Passage through S phase involves unwinding and rewinding of the genome. 
During this process, chromatin-remodeling complexes can potentially change the 
configuration of the genome in progenitor cells. Further, this can provide access for cell 
fate determinants to previously inaccessible parts of the genome and so influence cell fate 
determination (Fichelson et al., 2005; Holtzer et al., 1975; Ohnuma and Harris, 2003). 
 
 
Gap 2 (G2) phase  
The second 'gap' phase lies between the S phase and the M phase. In G2, 
progenitor cells prepare for mitosis. Checkpoints at the junction of G2/M phase ensure 
that entry into mitosis is halted if DNA replication is incomplete or defective (Johnson 
and Walker, 1999). The Cyclin A-Cdk2 complex is still the active driver of G2 and as its 
level builds up, it promotes enough Cyclin B1 expression for initiating mitosis (Fung and 
Poon, 2005; Lindqvist et al., 2009). It is postulated that the G2 phase is important for 
receiving signals that induce cell cycle exit and cell fate specification (Livesey, F. J. and 
Cepko, C. L., 2001). In the developing cortex, progenitor cells can be influenced in their 
cell fate decisions in late S/G2 phase (McConnell and Kaznowski, 1991). In the retina, it 
seems likely that amacrine cell fate specification occurs at G2 (Belliveau and Cepko, 
1999). Further, certain fate specification factors like OTX2 and cell cycle exit regulators 
as P27KIP1 also upregulated their expression in G2 (Dyer and Cepko, 2001; Trimarchi et 




Mitosis (M) phase  
Mitosis sees the equal distribution of genetic material of a progenitor cell into two 
of its daughter cells. The Cyclin B-Cdk1 complex is the driving force of mitosis, forming 
maturation promoting factor or mitosis promoting factor (MPF), first studied in frog 
oocytes as a factor that initiated mitosis (Gerhart et al., 1984; Lohka et al., 1988; Masui, 
2001; Masui and Markert, 1971). Cyclin B-Cdk1 drives progression of M phase up to the 
point where sister chromosomes are lined up at the centre, with the mitotic spindles 
pulling on them (Sullivan and Morgan, 2007). Beyond this point, the anaphase promoting 
complex (APC), an E3 ubiquitin ligase, promotes progression of the cell to G1 by 
mediating separation of sister chromatids and degradation of Cyclin B (Fung and Poon, 
2005; Sullivan and Morgan, 2007). Division of the cytoplasm during M phase is not an 
equal distribution of cellular content. Amongst factors that are asymmetrically distributed 
between daughter cells are cell fate determinants. The consequences of asymmetrical cell 
division in the nervous system/retina and cell fate specification are succinctly outlined in 
the following reviews (Cayouette and Raff, 2002; Cayouette and Raff, 2003; Cayouette et 
al., 2006; Gotz and Huttner, 2005; Malicki, 2004; Miyata, 2007; Zhong and Chia, 2008). 
 
 
Factors regulating RPC proliferation and precursor cell fate 
Regulation of RPC proliferation and determination of cell fate is critical for 
proper retinal histogenesis. The cell cycle is intimately associated with both of these 
processes. This section offers an overview of the major classes of determinants that 
influence retinal proliferation and precursor cell fate. Not surprisingly, G1 phase 
regulators feature prominently among these factors. 
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Homeobox genes 
Homeobox genes get their name from a highly conserved stretch of DNA, 180 
base pairs long (excluding introns). The homeobox encodes for a DNA binding motif, the 
homeodomain (McGinnis et al., 1984). Homeobox proteins bind DNA and usually code 
for transcription factors (Gehring et al., 1990; Gehring et al., 1994). They were first 
identified in the early 1980s in Drosophila homeotic genes, which are responsible for 
laying out the body plan during development (McGinnis et al., 1984; Scott and Weiner, 
1984). Since then, highly conserved homologs have been identified in many species 
where they perform similar functions. Homeobox genes are often classified by the 
presence of other conserved functional DNA binding motifs. Many homeobox genes 
influence cell fate specification in RPCs and precursors (Del Bene and Wittbrodt, 2005; 
Levine and Green, 2004; Wang and Harris, 2005).  
Several homeobox genes are expressed in RPCs from the earliest stages of eye 
development. Genes as Rx1, Lhx2, and Pax6 are important for early eye field 
specification, optic vesicle patterning, and maintenance of RPC proliferation. Some of 
these genes and their functions are discussed below. 
Rx1 is important for eye field specification. In Rx1 null mice, optic vesicles fails 
to form (Mathers et al., 1997). Misexpression of Rx, along with other factors, in 
pluripotent animal pole cells from Xenopus blastula induces formation of retinal cell 
types (Viczian et al., 2009). This indicates that Rx1 is also important for a retinal fate. 
 Lhx2, another homeobox gene, is essential for eye formation. Deletion of the 
Lhx2 arrests eye development at the optic vesicle stage, leading to anopthalmia (Porter et 
al., 1997; Tetreault et al., 2009; Yun et al., 2009). Lhx2 has been deemed crucial to link 
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intrinsic and extrinsic pathways of optic cup formation in early eye development. 
Germline deletion of Lhx2 leads to precocious neurogenesis. Conditional deletion of Lhx2 
later during development results in loss of RPCs and overproduction of stage specific 
precursors (Yun et al., 2009). This indicates a possible role of Lhx2 in maintenance of 
RPC identity (Yun and Levine, unpublished).  
Pax6 is a much studied homeobox gene. Targeted expression of the Pax6 
Drosophila homolog eyeless induces ectopic eye formation in flies, as does the Xenopus 
homolog of Pax6 in frogs (Chow et al., 1999; Halder et al., 1995). Loss of the Pax6 gene 
in mouse allows eye field determination but leads to developmental arrest of optic 
vesicles, premature neurogenesis, and loss of RPC multipotency (Baumer et al., 2002; 
Philips et al., 2005).  
Two other homeobox genes, Vsx2 and Sox2, are also important for maintenance of 
RPC identity, proliferation, and multipotency. Vsx2 expression is critical for the 
specification of retinal cells from RPE cells during early eye development (Horsford et al., 
2005; Rowan and Cepko, 2004). RPC proliferation is severely reduced in Vsx2 mutants, 
in part due to its role in cell cycle time regulation. Further, the onset of neurogenesis is 
delayed in the Vsx2 null retinas, indicating that the transition from pre-neurogenic to 
neurogenic RPC state may be delayed (Bone-Larson et al., 2000; Green et al., 2003; 
Sigulinsky et al., 2008). The requirement for Sox2 function in the retina was 
demonstrated in the Sox2 mutants. RPC proliferation is reduced in Sox2 null retinas and 
their capacity to produce neurons is severely impaired (Taranova et al., 2006). 
Homeodomain proteins exert their influence at most cell cycle phases. Prox1 
expression, required for horizontal cell specification in the retina, is seen at its highest 
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level in select RPCs at G2 (Dyer et al., 2003). This suggests PROX1 influences 
horizontal cell fate by functioning in G2. Six3 promotes RPC proliferation by repressing 
GEMININ, an inhibitor of S phase DNA replication, by direct binding (Del Bene et al., 
2004).  
Several homeobox genes that are expressed in the RPCs also maintain their 
expression in precursor cells. For example, VSX2 retains its expression in post-mitotic 
bipolar cells (Burmeister et al., 1996). Deletion of VSX2 results in complete elimination 
of bipolar cells (Green et al., 2003). Sox9 is expressed in RPCs during development and it 
maintains its expression in mature Müller glia cells. It is necessary for glia specification 
in the retina (Poche et al., 2008). Deletion of Sox9 severely reduces or eliminates Müller 
glia cells from the mouse retina (Muto et al., 2009; Poche et al., 2008). Sox2 is also 
expressed in a subset of amacrine cells and Müller glia cells. Forced expression of SOX2 
promotes the differentiation of these cell types (Lin et al., 2009). 
Other homeobox genes are expressed exclusively in post-mitotic retinal cells and 
are important for differentiation, cell fate specification, and maintenance of neurons 
(Ohsawa and Kageyama, 2008). A few examples are cited below.  
Pou4f2 (Brn3b) is expressed by almost 80% of newly born ganglion cell 
precursors. It is essential for maintenance of ganglion cell identity and ganglion cell 
survival (Badea et al., 2009; Gan et al., 1999; Qiu et al., 2008).  
Crx or the cone rod homeobox gene is expressed in photoreceptor precursors. Crx 
plays a critical role in photoreceptor precursor differentiation, identity, and maintenance 
(Freund et al., 1997; Furukawa et al., 1997; Morrow et al., 1998).  
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Otx2 is another homeodomain transcription factor expressed in photoreceptors 
and bipolar precursor cells. It is important for maintenance of photoreceptor and bipolar 
cell fates (Koike et al., 2007; Nishida et al., 2003).  
The above examples highlight the diversity in expression and function of the 
homeobox genes during development in all retinal cell types. A thorough appreciation of 
their function is essential for understanding retinal development. 
 
 
BHLH genes  
Another important group of retinogenesis determinants are the basic helix-loop-
helix (BHLH) family of transcription factors that are related to the Drosophila atonal and 
achaete-schute pro-neural genes (Vetter and Brown, 2001). BHLH factors can be broadly 
divided into two categories based on function. Repressor BHLH proteins maintain a 
RPC’s proliferative status and inhibit precursor formation. Activator or pro-neural BHLH 
factors promotes specific precursor cell fate and function (Hatakeyama and Kageyama, 
2004; Ohsawa and Kageyama, 2008). Repressor BHLH factors such as the Hes genes 
prevent differentiation of RPCs by repressing the pro-neural genes (Ishibashi et al., 1995; 
Van Doren et al., 1994). 
Hes1 and Hes5 belong to the Hes family of genes that are homologs of Drosophila 
Hairy and Enhancer of split (Sasai et al., 1992). Hes1 is expressed in RPCs during 
development in a cell cycle phase specific pattern (Das et al., 2009; Tomita et al., 1996) 
(Fig. 2.14). Germline deletion of Hes1 leads to loss of RPCs, premature differentiation of 
precursors, and a microphthalmic eye (Tomita et al., 1996). Hes5 is also expressed in the 
developing retina. Although Hes5 null retinas look normal, Müller glia population is 
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decreased, suggesting a role for Hes5 in glia specification. This notion is further 
supported by the fact that misexpression of Hes5 enhances Müller glia production (Hojo 
et al., 2000). Hes1, Hes5 double mutant embryos completely lack optic vesicles, 
indicating that these genes are able to compensate for each others' loss (Hatakeyama et al., 
2004). Hes1 and Hes5 are downstream targets of the Notch signaling pathway, which is 
itself required for maintenance of proliferative state in RPCs (Livesey, F. J. and Cepko, C. 
L., 2001; Perron and Harris, 2000). A recent study suggests that a combination of Notch 
receptors and downstream targets like Hes1 or Hes5 regulates production of retinal cell 
types (Riesenberg et al., 2009).  
Activator or pro-neural BHLH factors are associated with all cell classes in the 
retina and play a role in their genesis. A few of them are discussed below. 
Math5 is essential for ganglion cell formation and is expressed in a subset of 
RPCs that are about to exit from the cell cycle. Deletion of Math5 or its homologs leads 
to loss of ganglion cells in multiple species (Brown et al., 2001; Brown et al., 1998; 
Kanekar et al., 1997; Kay et al., 2001).  
Math3 and NeuroD are expressed in RPCs and regulate amacrine cell genesis. 
Combined deletion of Math3 and NeuroD results in complete ablation of amacrine cells 
(Hatakeyama et al., 2001; Inoue et al., 2002).  
Ptf1a is a BHLH transcription factor that is expressed in postmitotic horizontal 
and amacrine precursor cells. It is crucial for horizontal and amacrine cell specification 
(Fujitani et al., 2006; Nakhai et al., 2007). Deletion of Ptf1a results in a fate switch of 
horizontal/amacrine cells to ganglion cells (Fujitani et al., 2006; Nakhai et al., 2007). In 
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Xenopus retinas, Ptf1a promotes GABAergic neuronal cell fate over glycinergic cell fate 
(Dullin et al., 2007).  
Horizontal and amacrine cell fate specification pathways are closely related, and 
involve the action of Math3, NeuroD, Ptf1a along with genes like Prox1 and Foxn4 
(Ohsawa and Kageyama, 2008). Other BHLH genes like Barhl2 and Bhlhb5 are also 
expressed in amacrine precursors and are known to promote glycinergic and GABAergic 
amacrine cell formation, respectively (Feng et al., 2006; Mo et al., 2004).  
Mash1 and Math3 are expressed in bipolar precursor cells and are critical for 
bipolar cell specification (Jasoni and Reh, 1996; Takebayashi et al., 1997). Combined 
deletion of both genes leads to complete absence of bipolar cells (Tomita et al., 2000). 
Another factor Bhlhb4 is crucial for rod bipolar cell survival but not specification. Rod 
bipolar cells are generated in the absence of Bhlhb4. However, they fail to thrive and 
eventually undergo apoptosis (Bramblett et al., 2004).  
Typical BHLH factors such as those mentioned here usually act together with 
homeobox factors and other transcription factors in determination of RPC proliferation or 
precursor cell fate (Ohsawa and Kageyama, 2008). Thus, a complex network of signaling 
pathways and multiple classes of transcription factors control retinal histogenesis. 
 
 
Cell cycle regulators 
Cell cycle regulators are perfectly poised to influence proliferation and 
neurogenesis during development. Although regulators in all cell cycle phases can 
influence developmental processes in the retina, G1 phase regulators have received the 
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most attention. Therefore, this section will focus on G1 regulators, especially those in the 
retinoblastoma (RB) pathway. 
 
 
CDKI, RB, and E2F factors  
E2F1, E2F2, and E2F3 are transcriptional activators that are crucial for G1/S 
progression of progenitor cells. Although E2f1-/-, E2f2-/-, E2f3-/- triple null mouse 
embryonic fibroblasts (MEFs) are unable to progress into S phase, E2f1-/-, E2f2-/-, E2f3-/- 
mouse RPCs still proliferate due to compensation by the BHLH gene Nmyc (Chen, D. et 
al., 2009; Wu et al., 2001). In the retina, E2Fs mainly act downstream of RB proteins to 
prevent ectopic division of precursor cells due to cell cycle re-entry (Chen, H. Z. et al., 
2009). An isoform of E2F3, E2F3a, acts downstream of RB to affect starburst amacrine 
cell differentiation via a cell cycle independent mechanism (Chen et al., 2007).  
As mentioned before, the retinoblastoma protein family (Rb1, Rbl1/p107, and 
Rbl2/p130) regulates G1/S progression versus cell cycle exit. The loss of RB proteins in 
the retina results in ectopic proliferation and cell death (Chen et al., 2004; Dyer and 
Bremner, 2005). Rb1 is also involved in differentiation of rod photoreceptor cells (Zhang 
et al., 2004).  
The three CDKIs (p27Kip1, p57Kip2, and p19Ink4d) have a crucial role in 
promoting cell cycle exit. They are generally inhibitors of proliferation and their deletion 
leads to prolonged proliferation in the retina (Levine and Green, 2004). P27KIP1 and 
p57KIP2 are negative regulators of proliferation and are expressed in distinct populations 
of RPCs (Dyer and Cepko, 2000a; Dyer and Cepko, 2001; Levine et al., 2000). The 
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Xenopus homolog of KIP1, p27Xic1, is necessary and sufficient for Müller glia cell fate 
specification. This function is independent of its cell fate role (Ohnuma et al., 1999).  
 
 
D-type cyclins  
D-cyclins are small (33-34 kDa), evolutionarily conserved proteins that are the 
principal drivers of G1 (Sherr, 1995b). In humans, the three D-cyclins, Cyclin D1, D2, 
and D3, share high identity (~78%) within the CDK-binding ‘cyclin-box’ motif. However, 
outside the cyclin-box, identity is only at ~58%, suggesting significant divergence of 
functions amongst the D-cyclins (Xiong et al., 1992). It is believed that D-cyclins connect 
extracellular signaling pathways with the core G1 progression machinery (Matsushime et 
al., 1991; Paavonen et al., 1996; Pagano and Jackson, 2004; Sherr, 1994). No direct cell 
fate instructive roles for D-cyclins have been identified yet in the retina. However, G1 
regulation is intricately related to cell cycle exit and differentiation of precursor cells. 
Besides their better-known role in the cell cycle through CDK interaction, D-
cyclins have cell cycle-independent roles and can even act as a transcription factors 
(Coqueret, 2002; Fu et al., 2004; Li et al., 2006). Therefore, D-cyclins can potentially 
influence cell fate through both cell cycle dependent and independent mechanisms. 
In mice, the three D-cyclins are expressed in tissues-specific, dynamic, and often 
mutually exclusive patterns. Deletion of individual D-cyclins yields phenotypes reflecting 
their tissue-specific requirement (Ciemerych and Sicinski, 2005; Ciemerych et al., 2002; 
Pagano and Jackson, 2004; Sherr and Roberts, 2004). It was observed that development 
progressed relatively normally in most cellular lineages of mouse embryos lacking all D-
cyclins up to E16.5, at which point the embryos died due to severe anemia and heart 
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defects (Kozar et al., 2004). Despite reduced proliferation in triple knockout tissues, 
including the retina, D-cyclins seem mostly expendable for cell cycle progression (Kozar 
et al., 2004).  
 
 
Rationale for studies 
Cyclin D1 (Ccnd1) expression is strongest in the retina during mouse embryonic 
development; it is also significantly expressed in brain and other restricted tissue 
compartments (Sicinski et al., 1995). In the developing retina, CCND1 is expressed in 
RPCs but not in post-mitotic precursors and mature neurons (Barton and Levine, 2008; 
Trimarchi et al., 2008). Ccnd1 deletion or knockdown resulted in hypocellular retinas in 
mouse and zebrafish (Duffy et al., 2005; Fantl et al., 1995; Sicinski et al., 1995). Another 
study of Ccnd1-/- retinas demonstrated a focal pattern of photoreceptor cell death, 
initiating at around postnatal day 5 (Ma et al., 1998). Further, by [3H]Thymidine labeling 
of P0 retinas, it was demonstrated that proliferation was reduced in the Ccnd1-/- retinas 
compared to wild type/heterozygous control retinas (Ma et al., 1998). Reduction in 
proliferation was most likely responsible for almost a threefold decrease in total cell 
number of mutant retinas (Ma et al., 1998). Overall, CCND1 loss was detrimental for 
retina development, and electroretinogram (ERG) readings were essentially flat in the 
mutant mice, implying almost no visual function (Geng et al., 1999; Sicinski et al., 1995).  
It was clear from the hypo-proliferative and hypocellular P0 Ccnd1-/- retinas that 
CCND1 was required for proper retina development during the embryonic period. 
However, none of the studies elucidated the precise role of CCND1 during embryonic 
retinal development.  
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Therefore, we wanted to elucidate CCND1’s function in RPCs from the earliest 
possible time point. One important issue was whether cell death in the absence of 
CCND1 contributed to the smaller size of the mutant retina. Further, we could not 
formally rule out a cell cycle-independent role for CCND1 during retinal development. 
However, given the expression of CCND1 in dividing progenitors and the general role of 
D-cyclins, it was almost certain that CCND1 had cell cycle-specific functions in the 
retina. We wanted to know what these functions were and how the cell cycle of RPCs 
was affected in the absence of CCND1. Finally, given that D-cyclins usually promote 
G1/S progression, we were curious whether cell cycle progression and complementarily, 
differentiation/neurogenesis were affected in the Ccnd1 mutant retinas. The study 
described in Chapter 2 of this dissertation addressed the above issues during retina 
development in Ccnd1 null mouse embryos. 
It was observed that proliferation was not entirely eliminated from Ccnd1 null 
retinas at birth. Further, in spite of a smaller retina, a fair number of retinal neurons were 
generated in the mutant (Ma et al., 1998) (Chapter 2). Potentially, this could be due to 
compensation from the other two D-cyclins during development (Ciemerych et al., 2002; 
Satyanarayana and Kaldis, 2009). CCND2 is not normally expressed in the developing 
retina and CCND3 is expressed only in Müller glia cells (Dyer and Cepko, 2000b; Geng 
et al., 1999). However, a previous study demonstrated that CCND3 levels were 
prematurely elevated in Ccnd1 null neonatal retinas (Tong and Pollard, 2001). To address 
potential compensation by CCND3 in the Ccnd1 mutant retinas and further, to verify 
predictions arising from our first study (Chapter 2), we carried out the experiments 
described in Chapter 3 of this dissertation. 
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Figure 1.1: Overview of retina development. Cross section of anterior neural plate 
showing the eye field (A). The neural plate folds upward and in toward the midline (B). 
The two optic grooves evaginates and moves toward the surface ectoderm (C). The 
neural optic grooves are now in close contact with the non-neural surface ectoderm and 
cross talk ensues (D). The neural folds merge, the neural tube pinches off, and the 
presumptive retina, retinal pigmented epithelium (RPE), and optic stalk regions are 
patterned (E). The presumptive lens placode is also patterned from the surface ectoderm 
(E). The optic vesicle invaginates, bringing the retina in close apposition to the RPE and 
forms the optic cup. The lens placode also grows and invaginates. Retinal progenitor 
cells are yet to produce neurons and are pre-neurogenic (F). The optic cups grows 
circumferentially around the choroid fissure. Ganglion cells generated from retinal 
progenitors send out axons to form the optic nerve, which exits the eye through the 
choroid fissure. By this time, the lens has pinched off from the surface ectoderm (G). 
This structure now resembles the adult eye, retinal histogenesis is underway, and 
eventually other retinal neurons are also produced. Modified by permission from 
Macmillan Publishers Ltd: [Nature Reviews Neuroscience] (Evolution of the vertebrate 
eye: opsins, photoreceptors, retina and eye cup. Lamb TD, Collin SP, Pugh EN Jr. 2007 
Dec;8(12):960-76. Review.), copyright (2007).
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CHAPTER 2
CYCLIN D1 FINE-TUNES THE NEUROGENIC OUTPUT OF EMBRYONIC
 RETINAL PROGENITOR CELLS
The following chapter is a reprint of an article  coauthored by 
Gaurav Das, Yoon Choi, Piotr Sicinski, and Edward M. Levine
in the journal Neural Development 2009 May 5;4:15.
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Abstract
Background: Maintaining the correct balance of proliferation versus differentiation in retinal
progenitor cells (RPCs) is essential for proper development of the retina. The cell cycle regulator
cyclin D1 is expressed in RPCs, and mice with a targeted null allele at the cyclin D1 locus (Ccnd1-/
-) have microphthalmia and hypocellular retinas, the latter phenotype attributed to reduced RPC
proliferation and increased photoreceptor cell death during the postnatal period. How cyclin D1
influences RPC behavior, especially during the embryonic period, is unclear.
Results: In this study, we show that embryonic RPCs lacking cyclin D1 progress through the cell
cycle at a slower rate and exit the cell cycle at a faster rate. Consistent with enhanced cell cycle
exit, the relative proportions of cell types born in the embryonic period, such as retinal ganglion
cells and photoreceptor cells, are increased. Unexpectedly, cyclin D1 deficiency decreases the
proportions of other early born retinal neurons, namely horizontal cells and specific amacrine cell
types. We also found that the laminar positioning of horizontal cells and other cell types is altered
in the absence of cyclin D1. Genetically replacing cyclin D1 with cyclin D2 is not efficient at
correcting the phenotypes due to the cyclin D1 deficiency, which suggests the D-cyclins are not
fully redundant. Replacement with cyclin E or inactivation of cyclin-dependent kinase inhibitor
p27Kip1 restores the balance of RPCs and retinal cell types to more normal distributions, which
suggests that regulation of the retinoblastoma pathway is an important function for cyclin D1 during
embryonic retinal development.
Conclusion: Our findings show that cyclin D1 has important roles in RPC cell cycle regulation and
retinal histogenesis. The reduction in the RPC population due to a longer cell cycle time and to an
enhanced rate of cell cycle exit are likely to be the primary factors driving retinal hypocellularity
and altered output of precursor populations in the embryonic Ccnd1-/- retina.
Background
The vertebrate retina is composed of seven major cell
classes that arise from a common source, the retinal pro-
genitor cell (RPC) population. Although RPCs at any
given stage are largely multipotential, they are constrained
such that each cell class is generated in a temporal, albeit
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overlapping order. Production of retinal ganglion cells
(RGCs), horizontal cells, and cone photoreceptors is initi-
ated at the earliest stage of retinal neurogenesis, followed
by amacrine cells and rod photoreceptors, which is then
followed by bipolar cells and Müller glia. The relative pro-
portion of cells in each class differs widely. For example,
cones account for approximately 3% and rods approxi-
mately 97% of the photoreceptors in the mouse retina,
and rod photoreceptors are the most abundant cell class
accounting for approximately 70% of all retinal cells [1].
In general, the early-born cell classes constitute a much
smaller percentage of the retina than do the late-born cell
classes [1,3]. While cell death contributes to the final cell
distribution of the adult retina [4,6], the initial allocation
of precursor cells (that is, RPCs that exit the cell cycle) to
each class is a predominant factor in setting their relative
proportions.
In addition to generating the different cell classes, RPCs
need to proliferate in order to produce enough cells to
populate the retina. In the rat retina, RPC proliferation
drives an approximately 400-fold expansion of total cell
number in a 17-day period between embryonic day (E)14
and postnatal day (P)8 [7]. This interval also corresponds
to when the bulk of the RPC population exits the cell cycle
to generate precursors [2]. Thus, RPCs are exposed to com-
peting forces that either influence them to stay in the cell
cycle in order to produce enough cells or to exit the cell
cycle at the appropriate time in order to generate the cor-
rect proportion of cells corresponding to each cell class.
It is generally accepted that multiple cell-extrinsic and -
intrinsic factors play important roles in establishing the
correct balance between RPC proliferation and precursor
generation during development [8-10]. While it is impor-
tant to understand how these different factors are inte-
grated into networks, an understanding of the molecular
mechanisms used to exit the cell cycle during the transi-
tion from RPC to precursor is also needed.
D-type cyclins promote progression from G1 to S phase in
dividing cells by activating cyclin-dependent kinases 4 or
6 (CDK4/6) and by sequestering cyclin-dependent kinase
inhibitors such as cyclin-dependent kinase inhibitor 1B
(CDKN1B, henceforth referred to as P27KIP1) [11]. The
net result is enhanced CDK2 activity, inactivation of retin-
oblastoma proteins, and activation of DNA replication. D-
cyclins are also downstream of various signaling pathways
and, thus, are well positioned to co-ordinate cell cycle
progression with the extracellular environment [11,12].
Mice have three D-cyclin genes: cyclin D1 (Ccnd1), cyclin
D2 (Ccnd2) and cyclin D3 (Ccnd3). The expression and
requirement of the D-cyclins during development is tissue
specific [13]. Surprisingly, mouse embryos lacking all
three D-cyclins develop until E16.5, when they die due to
heart abnormalities combined with severe anemia [14].
Although developmental defects are apparent in these
mice prior to E16.5, proliferation of many tissues, includ-
ing the retina, still occurs, indicating that the D-cyclins are
not absolutely required for cell cycle progression.
Ccnd1 is the predominant D-cyclin in the developing ret-
ina and is highly expressed in RPCs but absent from exited
precursors and differentiated cells [15,18] (this study).
Zebrafish embryos treated with a Ccnd1 morpholino
exhibit small eye [19] and mice lacking Ccnd1 have small
eyes and hypocellular retinas due to reduced RPC prolifer-
ation and postnatal retinal cell death [17,20,21]. How-
ever, the impact of Ccnd1 on embryonic retinal
development has not been directly assessed.
In this study, we characterized the embryonic retinal phe-
notype in Ccnd1-/- mice. We found that the cell cycle rate
of the Ccnd1-/- RPC population is slower than normal and
this population undergoes a faster rate of depletion due to
an increased rate of cell cycle exit. Consistent with this,
RGCs and photoreceptors are overrepresented. Surpris-
ingly, other early-born embryonic cell classes in the retina,
namely horizontal and amacrine cells, are underrepre-
sented in the absence of Ccnd1. Analysis of retinas from
newborn mice in which Ccnd1 is replaced by Ccnd2 reveal
that the proportions of at least some cell types remain
altered, suggesting a unique requirement for Ccnd1 in
RPCs. We also analyzed the retinas of newborn mice in
which Ccnd1 is replaced by human Cyclin E (hCcne) or in
Ccnd1-/-, p27Kip1-/- double mutants and found that the
proportions of cell types approach a more normal distri-
bution. These findings led us to propose that Ccnd1 con-
trols the timing of cell cycle exit in embryonic RPCs and,
by doing so, contributes to the appropriate allocation of
precursor cells to each cell class. We also propose that
Ccnd1 contributes to the correct proliferative expansion of
the retina by influencing the time it takes for RPCs to tran-
sit through the cell cycle and by maintaining a sufficient
number of RPCs during the period of neurogenesis.
Materials and methods
Animals
Ccnd1-/- mice were purchased from Jackson Laboratories
(Bar Harbor, ME, USA). Drs Matthew Fero and James Rob-
erts (Fred Hutchinson Cancer Center, Seattle, WA) kindly
provided the p27Kip1-/- mice. The mouse strains contain-
ing the Ccnd2 cDNA targeted to the Ccnd1 locus (Ccnd1D2/
D2) and human Ccne cDNA targeted to the Ccnd1 locus
(Ccnd1hE/hE) were maintained in the Sicinski laboratory.
The noon of the day a vaginal plug was observed was des-
ignated E0.5. Genotyping was done as previously
described [17,22-24]. All animal use and care was con-
ducted in accordance with protocols approved by the Uni-
versity of Utah Institutional Animal Care and Use




Committee and set forth in the Association for Research in
Vision and Ophthalmology (ARVO) Statement for the
Use of Animals. Efforts were made to minimize discom-
fort to animals and, when possible, the number of ani-
mals needed per analysis was kept to a minimum.
Immunohistochemistry
Tissue preparation and immunohistochemistry were done
as previously described [25]. Radial cryosections through
the retina were cut at a thickness of 10 Pm. Primary anti-
bodies are listed in Table 1. Antigen unmasking (0.18 mM
citric acid, 77 PM sodium citrate, pH 6.0, 15 minutes, 90–
95°C) was performed prior to incubation with the prolif-
erating cell nuclear antigen (PCNA) antibody. Hydrochlo-
ric acid treatment (2N HCl, 30 minutes, room
temperature) was performed prior to incubation with the
bromodeoxyuridine (BrdU) antibody.
Image analysis
Sections were analyzed by epi-fluorescence using a Nikon
E-600 microscope and images captured in gray scale mode
with a Spot-RT slider CCD camera (Diagnostic Instru-
ments, Sterling Heights, MI, USA). Confocal images were
scanned using an Olympus Fluoview 1000 microscope.
Color (RGB) images were assembled from individual
monochrome channels using Photoshop CS (Adobe Sys-
tems Inc., San Jose, CA, USA). The levels function was
used to adjust the digital images to be consistent with vis-
ual observations.
Marker quantification and statistical analysis
The relative proportions, lineal densities, or areal densi-
ties of marker-positive (+) or -negative (-) cells were quan-
tified at E12, E14.5 and P0. For each genotype, a
minimum of three animals from at least two litters was
sampled. For each animal, three different non-adjacent
central-retina sections were used for cell counting.
At E12, epi-fluorescence images of whole retinal sections
were captured. Cell populations were quantified over the
total area of the sections (marker+ cells/mm2 retina). The
exception was for PCNA+ cells, which were quantified as a
percentage of the total cell population ((PCNA+ cells/
DAPI+ cells) × 100). PCNA+ population was sampled from
the dorsal retina, where neurogenesis initiates. At E14.5,
marker+ cells were calculated as a percentage of total cells
(marker+ cells/DAPI+ cells) from 400×-magnified confocal
images (1,600 × 1,600 resolution), captured at compara-
ble dorsal-medial regions. At P0, marker+ cells were quan-
tified as a percentage of total cells from confocal images of
medial-central retina, within 200 Pm of the optic nerve
head. Neurofilament medium (NEFM)+ horizontal and
SRY-box containing gene 2 (SOX2)+ amacrine cells were
quantified as a ratio of the unit length of apical surface of
the retina (marker+ cells/mm retina) because of their
sparse, linear distribution. The entire peripheral-central-
peripheral extent of individual sections was used for these
measurements. All cell counts, area, and length measure-
ments were done using Adobe Photoshop CS and ImageJ
(NIH). Students' t-test was performed using Kaleidagraph
statistical and graphing software (Synergy Software, Read-
ing, PA, USA) to determine statistical significance in the
marker+ cell population between mutant and control sam-
ples. In all graphs, numbers inside bars indicate the
number of samples analyzed. Error bars indicate standard
deviation.
Window-labeling using thymidine analogs to measure cell 
cycle times
Retinas with lens attached were cultured for 2.5 hours and
sequentially exposed to two thymidine analogs for
defined intervals. At P0, 5-iodo-2'-deoxy-uridine (IdU)
was added to the culture medium for the first 2 hours and
replaced with 5-bromo-2'-deoxy-uridine (BrdU) for the
final 30 minutes. At E14.5, BrdU was added to the culture
medium for the first 2 hours and replaced with 5-ethynyl-
2'-deoxy-uridine (EdU) for the final 30 minutes. As previ-
ously described [26-28], a combination of mouse anti-
BrdU (clone B44; BD Biosciences, San Jose, CA, USA) and
rat anti-BrdU (clone BU1/75; Serotec, Raleigh, NC, USA)
were used to detect the analogs at P0. For the E14.5 sam-
ples, the mouse anti-BrdU antibody was used to detect
BrdU (EdU is also detected), and EdU was specifically
detected using the Click-it Reaction (Molecular Probes,
Carlsbad, CA, USA) [29]. PCNA was used at both ages to
identify RPCs in all phases of the cell cycle [15]. The
length of the cell cycle (Tc) in hours was calculated by the
formulae:
or
and the length of the S-phase (Ts) in hours was calculated
by the formulae:
or
At E14.5 cell counts were done from a single central field
on each section (at least three sections per animal), gener-
ally on the same side. At P0, cell counts were done on six
fields spanning an entire section (at least of two sections
per animal). Dorsal-ventral orientation was lost upon dis-
( ) [ ]T  h PCNA  cells/IdU  only cells  at Pc = ×
+ +2 0
( ) [ ]T  h PCNA  cells/BrdU  only cells  at E14.5c = ×
+ +2
( ) [ ]T  h BrdU  cells/IdU  only cells  at P0s = ×
+ +2
( ) [ ]T  h EdU  cells/BrdU  only cells  at E14.5s = ×
+ +2




secting eyes out. A more detailed analysis of this assay will
appear in a forthcoming manuscript (GD and EML).
Cell cycle exit assay and RGC birthdating
Pregnant mice were injected once with a dose of BrdU (10
mg/ml stock in 0.1 M Tris (pH 7): 100 Pg/gm of body
weight injected) at E13.5 or E18.5 and sacrificed 24 hours
later at E14.5 and P0.5, respectively. Sections were co-
labeled with antibodies against BrdU and PCNA and
imaged by confocal microscopy. The cell cycle exit index
was calculated as the percentage of BrdU+ cells that were
PCNA- ((BrdU+, PCNA- cells/Total BrdU+ cells) × 100).
To measure the production of RGCs from RPCs, sections
from the same animals used for the cell cycle exit index
were co-labeled with antibodies against BrdU and POU
domain, class 4, transcription factor 2 (POU4F2; formerly
BRN3B). The index for RGC production was calculated as
the percentage of BrdU+ cells that were POU4F2+ ((BrdU+,
POU4F2+ cells/Total BrdU+ cells) × 100). Cell counts were
done from a single dorsal-central field per section (at least
two sections per animal) retina at E14.5. For P0 samples,
counts were done from two peripheral fields at opposite
ends per section (at least two sections per animal).
Results
CCND1 expression pattern during the early stages of 
retinal development
In the mouse retina, CCND1 protein is expressed as early
as E11 [17]. However, a systematic analysis of its expres-
sion pattern during early retinal development has not
been done. Therefore, we examined CCND1 expression
from E9.5 to E14.5, the period of optic cup formation and
onset of retinal neurogenesis (Figure 1). CCND1 protein
is expressed as early as E9.5 in several tissues that give rise
to the eye, including the optic vesicle and surface ecto-
derm, as well as in the adjacent diencephalic neuroepithe-
lium (Figure 1A). At E11, CCND1 expression is strongest
in the central region of the neural retina and in the lens
vesicle (Figure 1B), and the high level of CCND1 expres-
sion in the neural retina spreads outward by E12 and
reaches the peripheral retina by approximately E14.5 (Fig-
ure 1C, D). This dynamic pattern is reminiscent of the
wave of neurogenesis. To examine this relationship fur-
ther, these sections were also labeled with the Tuj1 anti-
body (Figure 1E–H), which detects the acetylated form of
class III beta-Tubulin (acTUBB3) and reveals the initial
formation of the differentiated cell layer (DCL) [30,31]. A
direct comparison of the CCND1 (dashed lines) and
acTUBB3 expression patterns (Figure 1I–L) indicates that
the high level of CCND1 expression in the neuroblast
Table 1: Primary antibodies
Antigen Host Target (relevant to this study) Dilution factor Source
BHLHB5 Goat amacrine precursors1 1000 Santa Cruz (sc-6045)
BrdU Mouse cells that have uptaken BrdU in S-phase 100 BD biosciences (clone B44)
BrdU Rat cells that have uptaken BrdU in S-phase 50-200 Serotec (clone BU1/75)
POU4F2 Goat RGC precursors 50 Santa Cruz (sc-6026)
CASPASE-3 Rabbit dying cells 500 BD biosciences (clone C92-605)
VSX2 Sheep RPCs 400 Exalpha Biologicals (X1180P)
CCND1 Rabbit RPCs 400 Lab Vision (RB-212)
CCND1 Mouse RPCs 400 Santa Cruz (clone 72-13G)
ISL1 Mouse amacrine cells 1 and RGCs 1 50 DSHB (clone 39.4D5)
HES1 Rabbit RPCs 800 Nadean Brown
MITF Mouse RPE 500 Exalpha Biologicals (clone C5)
NEFM Rabbit RGC and horizontal cells 1000 Chemicon (AB1987)
NR2E3 Rabbit rod precursors 100 Anand Swaroop
OTX2 Rabbit photoreceptor and amacrine precursors1 1000 Chemicon (AB9566)
OTX2 Goat photoreceptor and amacrine precursors1 400 Santa Cruz (sc-30659)
PAX6 Mouse RPCs 10 DSHB (clone P3U1)
PCNA Mouse RPCs 500 DAKO (clone PC10)
PCNA Rabbit RPCs 100 Santa Cruz (sc-7907)
pHH3 Rabbit mitotic cells 500 Upstate Biotechnology (06-570)
PTF1A Rabbit amacrine1 and horizontal precursors 800 Helena Edlund
RCVRN Rabbit photoreceptor cells 4000 Chemicon (AB5585)
RXRJ Rabbit cone and RGC precursors 200 Santa Cruz (sc-555)
SOX2 Rabbit RPCs and amacrine cells 1 400 Abcam (ab15830)
acTUBB3 Rabbit neuronal precursors 4000 Covance (PRB-435P)
acTUBB3 Mouse neuronal precursors 1000 Covance (clone TUJ1)
1marks a subset of cells in this class




layer (NBL) precedes the wave of acTUBB3 expression, but
their relative timing and similar patterns suggest they are
linked.
Patterning and apoptosis are unaltered by Ccnd1 
inactivation at embryonic ages
Since Ccnd1 is expressed during optic cup formation, the
hypocellularity of the Ccnd1-/- retina could be due to
altered regional patterning. However, analysis of several
markers of optic vesicle and cup patterning did not reveal
differences in the establishment or size of the neural reti-
nal domain (Additional file 1). Likewise, we did not
observe obvious differences in apoptosis at any of the
embryonic ages analyzed as revealed by activated caspase
3 (CASP3) immunoreactivity (Additional file 2) or by
TUNEL assay (data not shown).
Cell cycle time is longer in the Ccnd1-/- RPC population
Having ruled out major changes in retinal domain forma-
tion and cell death, we measured other parameters that
could cause the hypocellularity observed in the Ccnd1-/-
retina. At birth, Ccnd1-/- retinas show a three-fold decrease
in total cells and a concomitant three-fold decrease in cells
that incorporate tritiated thymidine [21]. While these
findings suggest reduced RPC proliferation prior to P0, we
directly analyzed proliferative activity during the embry-
onic period, first by detection of phosphorylated histone
H3 (pHH3), a marker of RPCs in M-phase (Additional file
3) [15]. Fewer pHH3+ cells are evident by E14.5, confirm-
ing that RPC proliferation is reduced in the embryonic
Ccnd1-/- retina.
To get an estimate of the cell cycle time and related meas-
ures, we adapted a window-labeling paradigm that uti-
lizes two thymidine analogs that can be differentially
detected [27] (manuscript in preparation). Frozen sec-
tions from P0 retinas were triple-labeled with a mouse
anti-BrdU antibody identifying both IdU and BrdU (Fig-
ure 2A, D), a rat anti-BrdU antibody identifying only BrdU
(Figure 2B, E) and an anti-PCNA antibody for labeling the
complete RPC cohort (Figure 2C, F) [15]. BrdU and EdU
on E14.5 sections were detected as described (see Materi-
als and methods).
Expression patterns of CCND1 and acTUBB3 during early retinal developmentFigure 1
Expression patterns of CCND1 and acTUBB3 during early retinal development. Wild-type retinas were double-
labeled with antibodies against (A-D) CCND1 and (E-H) acTUBB3. (I-L) Merged images. Dashed lines indicate the peripheral 
extent of strong CCND1+ cells in retinas from E11 (B, F, J), E12 (C, G, K), and E14.5 (D, H, L) embryos. Asterisks in (A, E, I) 
indicate that this region of the neuroepithelium is folded over in the section. Abbreviations: D, diencephalon; DCL, differenti-
ated cell layer; L, lens; NBL, neuroblast layer; NR, neural retina; OV, optic vesicle; PNR, presumptive neural retina; SE, surface 
ectoderm. Scale bars: 100 Pm; (K) is representative for (A-C, E-G, I-K); (L) is representative for (D, H, L).




We observed that the cell cycle time (Tc) of the Ccnd1-/-
RPC population was increased relative to that of the wild-
type RPC population at E14.5 and P0 (Figure 2G).
Although S phase time (Ts) did not vary between the two
genotypes at E14.5, there was a decrease in Ts for the
Ccnd1-/- RPC population at P0 (Figure 2G). We then sub-
tracted the S-phase time from cell cycle time (Tc - Ts),
which yields an estimate of the cumulative time spent in
G1, G2, and M phases, and found that the Tc - Ts value of
the Ccnd1-/- RPC population is significantly increased
compared to the wild-type RPC population at both ages
(Figure 2G). Since the function of Ccnd1 in the cell cycle
Retinal progenitor cell (RPC) cell cycle is lengthened in the Ccnd1-/- retinaFigure 2
Retinal progenitor cell (RPC) cell cycle is lengthened in the Ccnd1-/- retina. P0 wild-type and Ccnd1-/- retinas, cultured 
successively in iododeoxyuridine (IdU) for 2 hours and bromodeoxyuridine (BrdU) for 30 minutes, were triple-stained with 
mouse (A, D) anti-BrdU antibody (Ab) recognizing both IdU and BrdU, (B, E) rat anti-BrdU antibody recognizing only BrdU, 
and (C, F) with an antibody against PCNA marking RPCs. Arrows in (A-C) mark IdU+ only RPCs (IdU+, BrdU-; positive signal 
in (A, C) but not (B)) in wild-type retina that have moved up to the apical surface during the labeling period. Arrows in (D-F) 
mark IdU+ only RPCs (positive signal in (D, F) but not (E)) in the Ccnd1-/- retina during the same period. (G) Quantification of 
average RPC cell cycle time (Tc), S phase time (Ts) and G1 + G2 + M phase time (Tc - Ts) in wild-type (wt) and Ccnd1-/- retinas 
at E14.5 and P0. Scale bar: 50 Pm; (F) is representative for (A-F).




is thought to be specific to the G1 phase, this suggested
that the increase in Tc was due to a longer G1 phase,
although we cannot exclude potential changes in G2 or M
phases. In sum, these findings demonstrate that Ccnd1 is
required to ensure an appropriate rate of passage through
the cell cycle and that the slower rate of proliferation in
the absence of Ccnd1 is likely to contribute to the hypocel-
lularity of the Ccnd1-/-retina.
Increased cell cycle exit in the Ccnd1-/- retina reduces the 
relative size of the RPC population
In addition to a slower cell cycle rate, a reduction in size
of the RPC population due to enhanced cell cycle exit
could also contribute to the proliferation problems asso-
ciated with the hypocellularity of the Ccnd1-/- retina. To
assess this, we first examined the expression pattern of
PCNA and measured the proportion of PCNA+ cells rela-
tive to the total cell population at E12, E14.5 and P0 (Fig-
ure 3A–G). PCNA is expressed in the vast majority of RPCs
during development [15] and its expression characteristics
are not altered relative to other RPC markers in the Ccnd1-
/- retina (Additional file 4). While the distribution of
PCNA+ cells appears unchanged at E12 (Figure 3A, D), the
NBL is visibly thinner in the Ccnd1-/- retina at E14.5 (Fig-
ure 3B, E) and this is confirmed upon quantification (Fig-
ure 3G). At this stage, the thinning of the NBL layer occurs
at the expense of the DCL. At P0, the thinning of the NBL
is more pronounced (Figure 3C, F) and the proportion of
PCNA+ cells is reduced further (Figure 3G). In contrast to
E14.5, a gap in PCNA immunoreactivity is observed at the
apical side of the retina (brackets in Figure 3F), which is
filled by orthodenticle homolog 2 (OTX2)+ cells (Addi-
tional file 5A–F), indicating that these cells are predomi-
nantly post-mitotic photoreceptor precursors (see below).
A similar pattern of PCNA and OTX2 expression was
observed at E17.5 (data not shown).
These observations suggest that RPCs in the Ccnd1-/- retina
are exiting the cell cycle at a comparably more rapid rate
than normal. To assess this more directly, a cell cycle exit
index was measured for the interval between E13.5 to
E14.5, when RPC proliferation is robust and neurogenesis
is well underway, and later between E18.5 and P0.5 (Fig-
ure 3H–O; see Materials and methods). We observed that
a significantly greater proportion of BrdU+ RPCs exit the
cell cycle in the Ccnd1-/- retina compared to wild type at
both ages (Figure 3O), thereby indicating that increased
cell cycle exit is a primary cause for the reduction in RPCs
and is also a contributing factor in causing the hypocellu-
larity observed by birth in the Ccnd1-/- retina.
Enhanced cell cycle exit in the Ccnd1-/- retina leads to 
increased proportions of RGCs and photoreceptors, but 
not an earlier onset of neurogenesis
Enhanced cell cycle exit can lead to two non-mutually
exclusive changes in neurogenesis: an earlier onset or
enhanced neuron production from prematurely exiting
RPCs after onset. Importantly, either change could
increase the proportions of early born neuronal popula-
tions such as RGCs. To determine if neurogenesis initiates
earlier than normal in the Ccnd1-/- retina, we examined the
expression of acTUBB3 and the transcription factor
POU4F2, a marker of RGC precursors [32,33]. Cells posi-
tive for either marker were not observed at E11 or earlier
regardless of genotype (data not shown; Figure 4A, E).
Therefore, it is not likely that neurogenesis initiates early
in the Ccnd1-/- retina.
To determine whether Ccnd1 inactivation increases the
proportion of early-born neurons, we examined the
expression pattern of POU4F2 after the onset of neuro-
genesis (Figure 4B–D, F–H) and measured the percentage
of POU4F2+ cells relative to the total cell population at
E12, E14.5, and P0 (Figure 4I). Although the spatial pat-
terns of POU4F2+ cells in the Ccnd1-/- retina are similar to
wild type at E12 (Figure 4B, F) and E14.5 (Figure 4C, G),
their relative proportions are significantly higher in the
mutant at these ages and at P0 (Figure 4J). Additionally,
most wild-type RGCs are located below the inner plexi-
form layer (IPL; Figure 4D) at P0, but the mutant has an
extra layer of POU4F2+ cells positioned on the apical side
of the IPL (Figure 4H, arrows). A similar pattern of mislo-
calized POU4F2+ cells was also observed at E17.5 (data
not shown).
To confirm that the greater proportion of RGCs is corre-
lated with enhanced RPC cell cycle exit, we directly meas-
ured the proportion of RPCs that were becoming
POU4F2+ RGCs in a given time period. Using the same
samples as for the cell cycle exit assay described above, we
calculated the percentage of BrdU+ cells that express
POU4F2+. By this approach, we found that a significantly
higher percentage of BrdU+ RPCs exit the cell cycle and
form RGCs in the Ccnd1-/- retina from E13.5 to E14.5 (Fig-
ure 4J), confirming that enhanced cell cycle exit of Ccnd1-
/- RPCs leads to increased proportions of early born neu-
rons.
As described above, the apical 'gap' of PCNA expression in
the Ccnd1-/- retina is filled with OTX2+ cells (Additional
file 5D–F). Since OTX2+ cells include both cone and rod
precursors, we examined the P0 expression patterns of
retinoid × receptor gamma (RXRJ) and nuclear receptor
subfamily 2, group E, member 3 (NR2E3), which mark
cone and rod precursors respectively [34-36]. Consistent
with the increase in OTX2+ cells, the proportions of RXRJ+




cells (Figure 5A, D, G) and NR2E3+ cells (Figure 5B, E, H)
are increased in the Ccnd1-/- retina. The increased propor-
tion of photoreceptors is confirmed by the expression of
recoverin (RCVRN; Figure 5C, F, I), a calcium-binding
protein expressed in photoreceptors at perinatal ages [37].
Further, an apparent increase in cells expressing blue cone
opsin (OPN1SW) at P0 and rhodopsin at P4 (data not
shown) support our conclusion that cones and rods con-
tribute to the relative increase in photoreceptor produc-
tion.
Gradual depletion of retinal progenitor cell (RPC) population in the Ccnd1-/- retina is caused by enhanced cell cycle exitFigure 3
Gradual depletion of retinal progenitor cell (RPC) population in the Ccnd1-/- retina is caused by enhanced cell 
cycle exit. (A-F) Wild-type (wt) and Ccnd1-/- retinas were labeled with an antibody against PCNA from E12 to P0. Dashed 
lines in (A, B, D, E) demarcate the differentiated cell layer (DCL) from the neuroblast layer (NBL). Brackets in (F) show the 
'apical gap' in the P0 mutant retina. (G) Quantification of PCNA+ cells from E12, E14.5 and P0 retinas. (H) Schematic represen-
tation of cell cycle exit assay. (I-N) Wild-type and Ccnd1-/- retina samples, collected at 24 h following a single bromodeoxyuri-
dine (BrdU) injection at E13.5, were co-labeled with antibodies against PCNA and BrdU to measure rate of cell cycle exit, as 
outlined in (H). Arrowheads in (I-N) indicate cells that had exited the cell cycle in the last 24 h. (O) Quantification of exited 
cells (BrdU+, PCNA-) as a percentage of BrdU+ cells at E14 and P0.5. Abbreviations: DCL, differentiated cell layer; L, lens; NBL; 
neuroblast layer NR; neural retina. Scale bars: 100 Pm; (E) is representative for (B, E); (F) for (A, C, D, F); (N) for (I-N).




The proportions of horizontal and amacrine cells are 
reduced in the Ccnd1-/- retina, despite increased cell cycle 
exit
Since the decrease in the relative proportion of the RPC
population correlates with increased neurogenesis in the
embryonic Ccnd1-/- retina, it stands to reason that the pro-
portions of other early-born cell types, such as horizontal
and amacrine cells, would also be increased. We found,
however, that these cell types are in fact underrepresented
at E17.5 (data not shown) and P0 (Figure 6). Horizontal
cells, which express NEFM, are positioned in a single line
towards the outer part of the NBL (Figure 6A, arrows). In
the Ccnd1-/- retina, these cells are spaced further apart, and
displaced toward the IPL (Figure 6C, arrows). This reduc-
tion in horizontal cells is clearly indicated in retinal whole
mounts (Figure 6B, D), by quantification of their lineal
density on retinal sections (Figure 6E), and with other
markers of horizontal cells (aquaporin 4, prox1, and cal-
bindin; data not shown). We also observed a distinct
reduction in a subpopulation of amacrine cells marked by
SOX2 and islet1 (ISL1) co-expression (Figure 6F–L) [38].
Whereas SOX2+, ISL1+ cells appear as an orderly bi-layer
on both sides of the IPL (Figure 6F–H), the cells posi-
tioned below the IPL are mostly absent in the Ccnd1-/- ret-
Retinal ganglion cells (RGCs) are overproduced in the Ccnd1-/- retinaFigure 4
Retinal ganglion cells (RGCs) are overproduced in the Ccnd1-/- retina. (A-H) Wild-type (wt) and Ccnd1-/- retinas were 
stained with an antibody against POU4F2, which marks a majority of RGCs, at E11, E12, E14.5 and P0. Arrows in (H) mark the 
extra layer of RGCs in the Ccnd1-/- retina at P0. (I) Quantification of relative proportions of POU4F2+ RGCs. (J) Quantification 
of relative rate of POU4F2+ RGC production between E13.5 to E14.5. Abbreviations: DCL, differentiated cell layer; L, lens; 
NBL, neuroblast layer; NR, neural retina. Scale bars: 100 Pm; (G) is representative for (C, G); (H) for (A, B, D, E, F, H).




ina and the remaining cells are spaced further apart
(Figure 6I–K).
Ccnd1 deficiency has different effects on distinct 
precursor populations
Although our analysis of apoptosis (Additional file 2 and
data not shown) suggests that cell death is not contribut-
ing to the embryonic phenotype, we cannot entirely rule
it out as a factor in causing the reduction in horizontal
cells and SOX2+, ISL1+ amacrine cells as these cell types
are normally in low abundance. Furthermore, as it is hard
to discern NEFM+ horizontal cells during early neurogen-
esis and SOX2 expression is indicative of advanced stages
of maturation, the reductions in these markers could also
be due to delayed differentiation. This is unlikely, how-
ever, as cells expressing these markers continue to appear
reduced at later ages (data not shown). Another possibil-
ity is that the Ccnd1 deficiency is causing an underproduc-
tion in the post-mitotic precursors from which these
particular cell types arise. To address this, we examined
retinas at earlier stages of development using markers
expressed in newly generated precursors of horizontal,
amacrine, and photoreceptor cells (Figure 7). Pancreas
specific transcription factor, 1a (Ptf1a) encodes a basic
helix-loop-helix transcription factor expressed in horizon-
tal cell precursors and a subset of amacrine cell precursors
[39-41]. Basic helix-loop-helix family, member e22
(Bhlhe22, henceforth referred to as Bhlhb5) is another
Proportion of photoreceptor cells is increased in the Ccnd1-/- retinaFigure 5
Proportion of photoreceptor cells is increased in the Ccnd1-/- retina. Expression pattern of cone precursor marker 
(A, D) RXRJ, (B, E) rod precursor marker NR2E3, and (C, F) general photoreceptor marker RCVRN at P0. (G-I) Quantifi-
cation of relative proportions of RXRJ+, NR2E3+ RCVRN+ cells, respectively, at P0. Abbreviations: NR, neural retina. Scale 
bars: 100 Pm (D) is representative for (A, D); (E) for (B, E); (F) for (C, F).




basic helix-loop-helix factor expressed in embryonic pre-
cursors that give rise to GABAergic and displaced amacrine
cells [42]. Otx2 is predominantly expressed in photore-
ceptor precursors, although a subset of RGC and amacrine
precursors transiently express Otx2 at the start of their dif-
ferentiation [43-45].
Whereas a few cells in the E12 wild-type dorsal retina
express PTF1A, significantly fewer PTF1A+ cells are
detected in the Ccnd1-/- retina (Figure 7A, D, G). In con-
trast, BHLHB5+ cells, which are more abundant at this age,
do not differ in their relative proportions between the
wild-type and Ccnd1-/- retina (Figure 7B, E, G). OTX2
expression is evident in the retinal pigmented epithelium,
peripheral retina, and isolated cells in the NBL (Figure 7C,
F) and quantification of OTX2+ cells in the NBL reveals a
decrease in their proportion in the Ccnd1-/- retina (Figure
7G). This decrease is also reflected in RXRJ immunoreac-
tivity (data not shown), which suggests a drop in cone
precursor production at this age. At E14.5, the general
trends for each marker are similar to that found at E12
(Figure 7H–N), but it appears that the proportion of
OTX2+ cells is catching up in the mutant (Figure 7N). At
P0, the proportion of PTF1A+ cells remains reduced in the
Reduced densities of horizontal and amacrine cells in the Ccnd1-/- retinaFig r  6
Reduced densities of horizontal and amacrine cells in the Ccnd1-/- retina. (A, C) Expression pattern of NEFM at P0 is 
shown. Arrows point to representative horizontal cells. Bright staining in the differentiated cell layer (DCL) is due to NEFM 
expression in retinal ganglion cells (RGCs). (B, D) Retinal whole mounts stained with NEFM antibody reveal differences in 
horizontal cell density across retina. Tissues were imaged from basal surface to reduce interference from NEFM immunoreac-
tivity in RGCs. Insets show boxed regions. (E) Quantification of NEFM+ horizontal cells at P0. (F-K) Expression patterns of 
SOX2 (F, I) and ISL1 (G, J) at P0 (merged images in (H, K)) are shown. (L) Quantification of SOX2+, ISL1B+ amacrine cells at 
P0. Abbreviations: DCL, differentiated cell layer; NBL; neuroblast layer. Scale bars: 100 Pm; (C) is representative for (A, C); 
(D) for (B, D).




Ccnd1-/- retina (Figure 7O, R, U) and the relative propor-
tion of Bhlhb5+ cells does not differ between the wild-type
and Ccnd1-/- retina (Figure 7U), although their distribu-
tion is altered (Figure 7P, U). The relative proportion of
OTX2+ cells in the Ccnd1-/- retina is greater than in wild-
type at P0 (Figure 7Q, T, U) and the larger proportions of
RCVRN+, NR2E3+, and RXRJ+ cells (Figure 5) collectively
support the idea that, by P0, rod and cone precursor pro-
duction is enhanced in the absence of Ccnd1.
To gain insight into the potential relationships between
these precursor populations, we directly compared the
Ccnd1-deficiency causes alterations in the proportions of precursor cell populationsFigure 7
Ccnd1-deficiency causes alterations in the proportions of precursor cell populations. Expression patterns of (A, D, 
H, K, O, R) PTF1A, (B, C, I, L, P, S) BHLHB5 and (C, F, J, M, Q, T) OTX2 at E12 (A-F), E14.5 (H-M), and P0 (O-T) are 
shown. (G, N, U) Quantification of marker+ cells at E12 (G), E14.5 (N), and P0 (U). Abbreviations: DCL, differentiated cell 
layer; NBL, neuroblast layer; PR, peripheral retina; RPE, retinal pigmented epithelium. Scale bar: 100 Pm; (F) is representative 
for (A-F); (M) for (H-M); (T) for (O-T).




expression patterns of PTF1A, BHLHB5, and OTX2 at E12,
E14.5 and P0 (Figure 8). Regardless of age, PTF1A is not
expressed in the same cells as BHLHB5 or OTX2, which
suggests that PTF1A+ precursors are distinct from
BHLHB5+ precursors (Figure 8A, D, G, J, M, P) and OTX2+
precursors (Figure 8B, E, H, K, N, Q). In contrast, OTX2
and BHLHB5 are co-expressed in a subset of cells from
both populations (Figure 8C, F, I, L, O, R, arrowheads). At
E12, cells co-expressing OTX2 and BHLHB5 persist in the
Ccnd1-/- retina even though OTX2+ cells are fewer (Figure
8C, F). At E14.5 and P0, the majority of cells co-expressing
BHLHB5 and OTX2 are found in the NBL and not in the
apical layer of OTX2+ cells (Figure 8I, O), which are
instead marked by RXRJ or NR2E3 (data not shown), and
these relationships are maintained in the Ccnd1-/- retina
(Figure 8L, R; data not shown). These observations suggest
that the combinatorial expression of OTX2 and BHLHB5
marks multiple precursor populations. In sum, although
we cannot definitively rule out apoptosis or altered differ-
entiation as contributing factors, these data strongly sug-
gest that Ccnd1 inactivation alters the production of
specific cell populations from the earliest times after onset
of neurogenesis by altering the relative output of precur-
sor cells from RPCs.
Ccnd2 cannot completely rescue the Ccnd1-/- retinal 
phenotype
Genetic replacement of Ccnd1 by Ccnd2 in Ccnd1D2/D2
knock-in mice restores the histological appearance of the
adult retina and electroretinographic response of photore-
ceptors [22]. In this model, the Ccnd2 cDNA sequence is
inserted into the Ccnd1 locus and regulated by the Ccnd1
promoter and enhancer elements. We examined the P0
retina in these mice to determine if Ccnd2 is sufficient to
correct the developmental changes due to Ccnd1 defi-
ciency (Figure 9). PCNA immunolabeling reveals that,
similar to the Ccnd1-/- retina, the RPC layer is thinner in
the Ccnd1D2/D2 retina compared to its wild-type control,
with a 'gap' at the apical surface (Figure 9A, B; brackets in
B) that is filled with OTX2+ cells (Additional file 5J–L).
Scoring of PCNA+ cells reveals that their proportion is sig-
nificantly reduced (Figure 9E). Unlike the Ccnd1-/- retina,
POU4F2+ cells are not mis-positioned on the apical side of
the IPL layer (Additional file 6E). Quantification of
NEFM+ horizontal cells revealed a significant decrease in
their numbers (Figure 9F, G, J) although not to the same
magnitude as in the Ccnd1-/- retina (Figure 6E). In agree-
ment with this trend, there appear to be fewer PTF1A+,
SOX2+, and BHLHB5+ cells in the Ccnd1D2/D2 retina com-
pared to its wild-type control (Additional file 6B–D, F–H).
These findings indicate that Ccnd2 is not sufficient to
completely compensate for Ccnd1 in retinal cell produc-
tion.
Genetic manipulation of downstream cell cycle regulators 
minimizes the impact of the Ccnd1 deficiency on 
embryonic retinal development
Genetic and biochemical evidence suggests that the rate-
limiting function of Ccnd1 in promoting cell cycle pro-
gression is to stimulate Ccne activity [23]. Based on this
model, the altered cell production in the Ccnd1-/- RPC
population could be due to limited Ccne activity. To
address this, we analyzed the newborn retina in a mouse
strain in which the human Ccne cDNA is inserted into the
Ccnd1 locus. In this strain, referred to as Ccnd1hE/hE,
human Ccne is expressed in place of Ccnd1. Similar to the
Ccnd1D2/D2 mouse, the adult retina in this model appears
histologically normal and electrophysiological properties
are better than in the Ccnd1-/- retina [23].
Our initial analysis revealed that the Ccnd1hE/hE retina is
thinner than its wild-type counterpart, which may be due
to an increase in apoptosis, especially in the NBL (Figure
9K–N). In contrast to the Ccnd1-/- and Ccnd1D2/D2 retinas,
PCNA staining shows that the RPC layer extends all the
way to the apical edge, similar to the wild-type control
(Figure 9C, D). Whereas the proportions of PCNA+ and
NEFM+ cell populations are not significantly different
from wild type, they exhibit downward trends (Figure 9E,
H, I, J). The relative proportions and positions of cells
expressing POU4F2, PTF1A, SOX2, and BHLHB5 appear
to be similar between the Ccnd1hE/hE and its wild-type con-
trol retina (Additional file 6I–P). These findings suggest
that Ccne is more efficient than Ccnd2 in replacing Ccnd1
to control the balance of retinal cell types produced.
The sequestration of P27KIP1 by CCND1 protein is one
mechanism by which CCND1 is predicted to enhance
CCNE activity and promote cell cycle progression [11].
Consistent with this, genetic inactivation of p27Kip1 alle-
viates many of the phenotypes seen in the Ccnd1-/- mouse
[46,47]. Furthermore, ectopic proliferation occurs in the
p27Kip1-/- retina and its overexpression inhibits RPC pro-
liferation [48,50]. To test whether the removal of p27Kip1
restores the balance of cell types in the absence of Ccnd1,
we analyzed Ccnd1-/-, p27Kip1-/- double mutant retinas at
P0 (Additional file 7). We found that the expression pat-
tern of PCNA in the double mutant retina is more similar
to the control retina (Ccnd1+/-) than to the Ccnd1-/- retina,
which is indicated by the absence of an 'apical gap' in
staining (Additional file 7A, G, S). The cellular distribu-
tions of POU4F2+ RGCs, NEFM+ horizontal cells as well as
other cell populations expressing PTF1A, SOX2, and
BHLHB5 in the double mutant also appear more similar
to the control patterns than those in the Ccnd1-/- retina
(Additional file 7B–F, H–L, T–X). For comparative pur-
poses, the expression patterns for these markers in the
p27Kip1-/- retina are shown in Additional file 7M–R. The
sum of our observations from the Ccnd1hE/hE and Ccnd1-/-,




p27Kip1-/- mice suggest that Ccnd1's influence on precur-
sor cell output is dependent on its role in regulating Ccne
and p27Kip1.
Discussion
We report here that Ccnd1 has important functions in reg-
ulating embryonic retinal histogenesis. In addition to
hypocellularity due to changes in proliferation, the rela-
tive proportions of multiple post-mitotic precursor popu-
Relationship between PTF1A+, BHLHB5+, and OTX2+ precursorsFigure 8
Relationship between PTF1A+, BHLHB5+, and OTX2+ precursors. Retinal sections at (A-F) E12, (G-L) E14.5, and 
(M-R) P0 were double-labeled with combinations of antibodies against PTF1A, BHLHB5 and OTX2. Arrowheads in (C, F, I, L, 
O, R) show examples of cell co-expressing OTX2 and BHLHB5. Arrows in (B, C, E, F, H, I, K, L) point to the retinal pigmented 
epithelium (RPE). Abbreviations: DCL, differentiated cell layer; NBL, neuroblast layer; RPE, retinal pigmented epithelium; wt, 
wild type. Scale bar: 100 Pm; (R) is representative for all panels.




lations are altered in the Ccnd1-/- retina. RGC precursors
are overrepresented, and horizontal cell and a subset of
amacrine cell precursors are underrepresented in the
Ccnd1-/- retina relative to wild type. Photoreceptor precur-
sors, while underrepresented early on, are overrepresented
later. Since overall cell number is lower in the mutant ret-
ina [21], our data suggest that the initial reduction in pho-
toreceptor precursors and the apparent permanent
reduction in horizontal and amacrine cell precursors
reveals a true reduction in their numbers compared to
wild type. While it is not known if the absolute number of
RGCs and photoreceptors differs from wild type, our data
show that their relative contributions to the cell composi-
tion of the Ccnd1-/- retina is greater than in wild type.
Analysis of Ccnd1D2/D2 and Ccnd1hE/hE retinas at P0Figure 9
Analysis of Ccnd1D2/D2 and Ccnd1hE/hE retinas at P0. (A-D) Expression pattern of PCNA) in Ccnd1D2/D2 retina (B), Ccnd1hE/
hE retina (D) and their respective wild-type (wt) controls (A, C) is shown. (E) Quantification of proportions of PCNA+ cells. 
(F-I) Expression pattern of NEFM in Ccnd1D2/D2 retina (G), Ccnd1hE/hE retina (I) and their respective wild-type controls (F, H) is 
shown. (J) Quantification of NEFM+ cells. (K, L) TUNEL labeling in wild-type (K) and Ccnd1hE/hE retina (L). (M, N) Activated 
CASP3 immunoreactivity in wild-type (M) and Ccnd1hE/hE retina (N). Brackets in (B) show the 'apical gap' in the P0 Ccnd1D2/D2 
retina. Abbreviations: NR, neural retina. Scale bar: 100 Pm (N is representative for all panels).




The changes outlined above are likely to be the result of
Ccnd1's roles in the cell cycle. Since cell cycle transit time
is longer and the relative rate of cell cycle exit is enhanced
in the absence of Ccnd1, it is possible that these changes
in proliferation are linked. While longer cell cycle times
are predictive of increased cell cycle exit in the brain
[51,52], this does not appear to be the case in the
zebrafish retina [53,54]. So whether the lengthening of
the cell cycle directly causes enhanced cell cycle exit in the
Ccnd1-/- retina is not clear. Regardless, we propose that
Ccnd1 is required for establishing the proper balance of
cell types produced during embryonic retinal develop-
ment by mediating cell cycle exit, or in other words, the
rate of precursor output from RPCs.
Ccnd1 regulates the timing of cell cycle exit in a limited 
manner after the onset of neurogenesis
Interestingly, not all Ccnd1-/- RPCs exit prematurely, and
the extent of RPC depletion, while significant, is not
severe. A reasonable percentage of Ccnd1-/- RPCs remain in
the cell cycle even as neurogenesis progresses. This is not
due to restricted expression as Ccnd1 is widely expressed
in RPCs and throughout most of the cell cycle (this study)
[15,18]. Rather, D-cyclins are not absolutely required for
proliferation in embryonic RPCs since proliferation still
occurs in mice deficient in Ccnd1, Ccnd2, and Ccnd3 [14].
We also found no evidence that Ccnd1-/- RPCs exit the cell
cycle before the normal onset of neurogenesis even
though Ccnd1 is abundantly expressed as early as E9.5.
This is not because RPCs are inherently unable to initiate
neurogenesis early since precocious neurons are produced
in the paired box gene 6 (Pax6-/-) and hairy and enhancer
of split 1 (Hes1-/-) retinas [55,57]. Furthermore, the
spreading wave of neurogenesis is not altered in the
Ccnd1-/- retina, even though wild-type RPCs increase their
level of CCND1 expression just ahead of the neurogenic
wave. These observations led us to propose a model stat-
ing that once neurogenesis begins, a limited number of
RPCs become Ccnd1-dependent and their timing of cell
cycle exit is determined by their level of CCND1 expres-
sion or activity (Figure 10A). We also predict that Ccnd1-
dependent RPCs are generated continuously during reti-
nal development and have limited proliferative potential.
Otherwise, Ccnd1 deficiency should have caused a more
discontinuous or severe decline in the RPC population. It
appears then that downregulation of Ccnd1 is an impor-
tant step in the transition of RPCs to post-mitotic precur-
sors. Consistent with this, forced expression of CCND1 in
photoreceptor precursors causes unscheduled prolifera-
tion, differentiation defects, and apoptosis [58].
Mechanism of Ccnd1-mediated cell cycle exit
D-cyclins regulate the retinoblastoma pathway by binding
to and activating CDK4/6 and by sequestering CDK2
inhibitors such as P27KIP1 [11]. Both mechanisms ulti-
mately lead to inactivation of retinoblastoma proteins by
CDK2/4/6-mediated phosphorylation, allowing cells to
progress from G1 to S phase and undergo DNA replica-
tion. Although the importance of the retinoblastoma
pathway in continuously cycling cells is not clear, it is crit-
ical in many cell lineages for differentiation [59-61]. In
the mouse retina, genetic deletion of the retinoblastoma
proteins (Rb1, Rbl1/p107, or Rbl2/p130) uncouples cell
cycle exit and differentiation, resulting in ectopic prolifer-
ating cells that express markers of multiple precursor cell
types in the retina [62,65]. Further evidence of this decou-
pling is seen in the postnatal p107 single copy mutant ret-
ina where mature horizontal cells proliferate extensively,
all the while retaining their differentiated characteristics
[66]. This suggests that retinoblastoma pathway activity
regulates cell cycle exit of RPCs and controls the post-
mitotic state for some period of time after cell cycle exit.
Additional evidence to this effect comes from genetic
studies of molecular regulators in this pathway: inactiva-
tion of cyclin-dependent kinase inhibitors such as
p27Kip1, p57Kip2, and p19Ink4d cause ectopic prolifera-
tion [9,48,50,67]. Forced expression of Ccnd1, the large T-
antigen from simian virus 40 or the human papillomavi-
rus type 16 (HPV-16) E7 protein (negative regulators of
retinoblastoma proteins) in post-mitotic photoreceptor
precursors causes inappropriate cell cycle re-entry and
subsequent cell death or tumorigenesis depending on the
nature of the transgene construct [58,68-72]. A similar
phenomenon is also observed for other retinal cell types
[73,75]. Furthermore, Rb1 phosphorylation is greatly
diminished in the Ccnd1-/- retina, probably due to reduc-
tions in CDK2 and CDK4 activities [23,46,47,76]. Since
the retinoblastoma proteins are expressed in dynamic and
temporal patterns in mouse RPCs [60,64,77], their expres-
sion levels in individual RPCs may determine the timing
of Ccnd1-dependence (Figure 10A). However, other
mechanisms such as extracellular signaling are also likely
to contribute to tempering retinoblastoma protein activity
in continuously cycling RPCs [12].
Our results indicate that Ccnd2 may not influence RPC
cell cycle exit in the same manner as Ccnd1. Although the
retina in the Ccnd1D2/D2 mouse is not as severely affected
as in the Ccnd1-/- mouse, cell production is not restored to
normal proportions. Limited Ccnd2 expression is not the
likely reason for this [22]. Rather, molecular analyses indi-
cate that CCND2 activity is not identical to CCND1
[22,46,47,78]. The newborn Ccnd1hE/hE retina also has a
more normal cellular composition than the Ccnd1-/- retina
and may surpass the extent of rescue in the Ccnd1D2/D2 ret-
ina. Interpretation of the phenotype is complicated by
enhanced cell death, which is not observed in the new-
born Ccnd1-/- or Ccnd1D2/D2 retinas. This is probably due
to high hCcne expression as endogenous Ccne is normally
expressed at low levels [18] (unpublished observations).




Models of Ccnd1 function in the retinaFigure 10
Models of Ccnd1 function in the retina. (A) General model of Ccnd1-dependence in retinal progenitor cells (RPCs). Most, 
if not all RPCs express CCND1. At least one division before cell cycle exit, RPCs become dependent on CCND1 to remain in 
the cell cycle (RPCs in gray box). Those that retain sufficiently high Ccnd1 levels or activity continue to divide whereas those 
that drop below a threshold will produce at least one post-mitotic precursor cell (P). It is not known if the other daughters of 
each division are Ccnd1-dependent, nor is the mode of division known for Ccnd1-dependent RPCs. It is presumed that at least 
some of the RPCs that persist contribute to the RPC population at later stages. (B) Model of how cell production is altered in 
the absence of Ccnd1 during early retinal development. In the wild-type retina, a proportion of CCND1-dependent RPCs will 
produce precursors that differentiate into cone, horizontal, or amacrine cells (O/P). In the Ccnd1-/- retina, Ccnd1-dependent 
RPCs exit at least one division sooner, resulting in a gradual reduction in the size of the RPC population and an enhancement 
in the relative production of retinal ganglion cell (RGC) precursors at the expense of other precursor types. This could be due 
to an instructive role for Ccnd1 in cell fate specification or to a consequence of RPC competence and/or altered environment 
at the time of exit. The inability of RPCs to replenish the PTF1A precursor population (as it does for the OTX2 precursor pop-
ulation) suggests that most RPCs lose their competence to make PTF1A precursors (R*). Similar mechanisms may influence the 
output of other precursor populations.




While hCcne may rescue premature cell cycle exit due to
the Ccnd1 deficiency, it could also activate apoptosis by
causing an incompatible activation of proliferation and
differentiation pathways in precursor cells. Nevertheless,
instead of functionally replacing Ccnd1, ectopically
expressed hCCNE bypasses the retinoblastoma proteins
[23], by partnering with CDK2 to induce S-phase entry
without sufficient RB1 phosphorylation [79]. A similar
bypass mechanism appears to be operating in the Ccnd1-/
-, p27Kip1-/- retina [46,47] and the more normal distribu-
tion of cell types in the newborn Ccnd1-/-, p27Kip1-/- retina
at P0 supports the idea that p27Kip1 is downstream of
Ccnd1 in regulating the production of precursor popula-
tions. The sum of these findings agrees with the model
that Ccnd1-mediated regulation of the retinoblastoma
pathway is an important mechanism for controlling the
timing of cell cycle exit in embryonic RPCs.
Ccnd1 influences the production of precursor cells 
allocated to multiple cell types
In multipotential progenitor cell lineages, enhanced rates
of cell cycle exit tend to cause reductions in late-born cell
types that may or may not be accompanied by increases in
the production of early-born cell types [55,57,80-83].
Interestingly, the changes in cell production that occur in
the embryonic Ccnd1-/- retina diverge from this general
rule. RGC production is enhanced whereas unexpectedly,
production of other early-born cell types, namely hori-
zontal cells, SOX2+, ISL1+ amacrine cells, and cones (ini-
tially), is reduced, and these types of alterations are
indicative of changes in cell fate specification (Figure
10B). Since Ccnd1 is expressed in RPCs and not in post-
mitotic precursors, how might Ccnd1 inactivation pro-
duce these changes?
One possibility is that Ccnd1 has an instructive role in ret-
inal cell fate determination, similar to Ccne in the thoracic
NB6-4 neuroblast lineage in Drosophila [84]. Ccnd1 may
prevent a subset of early neurogenic RPCs from becoming
RGCs by directing them toward horizontal, amacrine, or
cone cell fates. Indeed, production of PTF1A+ precursors is
reduced in the Ccnd1-/-retina, and Ptf1a inactivation
results in a cell fate switch from horizontal and amacrine
cells to RGCs [39-41]. Although OTx2+ (and RXRJ+) pre-
cursors are also underrepresented in the Ccnd1-/- retina at
E12 and E14.5, it is unclear how Ccnd1 could instruct
photoreceptor fate since inactivation of OTx2 in photore-
ceptor precursors causes conspicuous amacrine cell over-
production and apoptosis by P0 [45], two changes not
observed in the Ccnd1-/- retina. Regardless, if Ccnd1 is
instructive for cell fate, we predict that the mechanism
involved could operate independently of its role in timing
RPC cell cycle exit since altering precursor cell fates does
not necessarily involve changes in proliferation.
Another possibility is that Ccnd1 deficiency could produce
cell fate changes that are linked to the altered timing of
cell cycle exit (Figure 10B). In this scenario, an early neu-
rogenic, Ccnd1-dependent RPC is competent to become
an RGC, but is prevented from doing so because it
expresses CCND1 and stays in the cell cycle. As CCND1
levels drop below a threshold in a subsequent cell cycle,
the RPC exits and differentiates into the other early-born
cell types (that is, horizontal, amacrine, cone; O/P precur-
sor in Figure 10B) because of changes in its competence
and/or in its surrounding environmental milieu. In the
absence of CCND1, the Ccnd1-dependent RPC exits at
least one cell cycle sooner and differentiates into an RGC
at the expense of other early-born cell types (Figure 10B).
Attractive features of this model are that it incorporates
current ideas on retinal development: that RPCs are
multipotential; that temporal shifts in RPC competence
occur as development progresses; and that the concerted
actions of cell-extrinsic and -intrinsic pathways mediate
cell fates [85]. Importantly, it doesn't invoke a function
for Ccnd1 beyond controlling the timing of cell cycle exit.
An unresolved issue, however, is that while this model
accounts for enhanced RGC production early and pho-
toreceptor production late, it fails to explain the persistent
underproduction of other early-born cell types in the
mutant. If RPCs are multipotential and premature cell
cycle exit is a continuous and ongoing process in the
Ccnd1-/- retina, then the RPCs that exit subsequently
should compensate for the earlier exited RPCs and pro-
duce the precursors that are initially underproduced.
While this is observed for the OTX2+, RXRJ+ precursors
(cones), production of PTF1A+ precursors (horizontal
cells and some amacrine cells) fails to 'catch up'. One pos-
sibility is that most RPCs lose their competence to pro-
duce PTF1A+ precursors (R* in Figure 10B). In the Ccnd1
mutant, the PTF1A-incompent RPCs are unable to com-
pensate for the early underproduction of PTF1A+ precur-
sors; thereby resulting in a permanent deficit in these
precursors and the cell types they give rise to.
The BHLHB5+ cell population is unique in that its propor-
tion does not vary between the wild type in the Ccnd1-/-
retina, at least up to P0. Given the idea that subsets of
RPCs may utilize different proteins to control cell cycle
exit [18], BHLHB5+ precursors may not require Ccnd1 to
regulate the number of RPCs needed for their production.
The fact that the proportion of BHLHB5+ precursors
remains consistent may also be an indication that produc-
tion of this cell population is dependent on non-cell
autonomous feedback signaling [86-88].
As mentioned at the start of this section, a more rapid rate
of RPC depletion due to enhanced neurogenesis should
cause a reduction or absence in the last generated cell




types. Interestingly, rods, bipolar cells, and Müller glia are
present in the postnatal Ccnd1-/- retina as are PCNA+ cells
[21] (unpublished observations), which indicates that
RPCs persist until the last stages of normal histogenesis.
This could occur if our model of Ccnd1-dependence in
embryonic RPCs also holds for postnatal RPCs. If true,
then the rate of RPC decline may not be steep enough to
deplete the population prior to production of the last-
born cell types, although again, we would expect a drop in
their numbers. Our observation of an increased propor-
tion of rod precursors at P0 suggests that they are being
produced at the expense of bipolar cells and Müller glia,
similar to what may be happening for RGC precursors and
the other early-generated precursor populations. Assess-
ing this is difficult, however, because of the extensive cell
death in the postnatal Ccnd1-/- retina, when bipolar cells
and Müller glia are being produced [21,89]. Alternatively,
RPCs in the postnatal period may not require Ccnd1 to
control timing of cell cycle exit, and one possible explana-
tion is that Ccnd3 takes over, a scenario analogous to D-
cyclin utilization in cerebellar granule precursors, which
depend on Ccnd1 early and Ccnd2 late, to produce the cor-
rect number of granule cells [82,90]. Ccnd3 is normally
expressed in Müller glia and possibly in RPCs at the end
of histogenesis (that is, P5 and older). Importantly,
CCND3 expression is upregulated by P0 in the Ccnd1-/-
retina (unpublished observation) [47], which suggests a
possible compensatory mechanism for maintaining post-
natal RPCs.
Does Ccnd1 regulate laminar positioning of retinal cells?
Retinal cells occupy distinct locations in the retina and
cells of the same cell type generally occupy the same lam-
inar position. Unexpectedly, we found that the locations
of cells belonging to several different classes are altered in
the Ccnd1-/- retina. For example, RGCs are distributed on
both sides of the IPL and horizontal cells are positioned
closer than normal to the IPL. Why this occurs is not clear,
but Ccnd1 can influence cell migration via the ROCK
pathway [91,92]. Important to note, however, is that hor-
izontal cells briefly reside in this position during their
normal course of differentiation [93,94]. Whether Ccnd1
has a direct role in regulating precursor cell positioning/
migration or if these changes are due to indirect effects of
altered differentiation or because of compromised cell-
cell interactions due to the changes in the proportions of
retinal cell types awaits further analysis.
Conclusion
This study elucidates the roles of Ccnd1 in embryonic ret-
inal development. We show that Ccnd1 is expressed glo-
bally in RPCs and contributes to two aspects of
proliferation control – the rate of cell cycle progression
and the timing of cell cycle exit. Ccnd1 is also required to
ensure that precursor populations are produced in their
appropriate proportions. We propose that Ccnd1 does this
through its control of cell cycle exit and that the perma-
nent reduction in the PTF1A+ precursor population in the
Ccnd1-/- retina is the result of a temporal shift in RPC com-
petence. More studies are needed to address whether
Ccnd1 also has a direct role in regulating precursor fates
and, if so, whether p27Kip1 or other cell cycle regulators
that are downstream of Ccnd1 are involved. This work
provides further evidence for the model that cell cycle reg-
ulators contribute to the neurogenic output of multipo-
tential progenitor populations.
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Expression domains of neural retina and retinal pigmented epithelium 
markers are not altered in the Ccnd1-/- eye prior to the onset of neu-
rogenesis. Wild-type and Ccnd1-/- retinas at E9.5 and E11 were stained 
with antibodies against (A, B, I, J) PAX6, (C, D, K, L) SOX2, (E, F, 
M, N) VSX2 and (K, L, O, P) MITF. The asterisk in (D) indicates that 
this region of the neuroepithelium is folded over in the section. Abbrevia-
tions: NR, neural retina; OV, optic vesicle; PNR, presumptive neural ret-
ina; PRPE, presumptive retinal pigmented epithelium; RPE, retinal 
pigmented epithelium. Scale bar: 100 Pm; (P) is representative for (A-P).
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Figure 2.11. (Additional file 1) Expression domains of neural retina and retinal 
pigmented epithelium markers are not altered in the Ccnd1-/- eye prior to the onset 
of neurogenesis. Wild-type and Ccnd1-/- retinas at E9.5 and E11 were stained with 
antibodies against (A, B, I, J) PAX6, (C, D, K, L) SOX2, (E, F, M, N) VSX2 and (K, L, 
O, P) MITF. The asterisk in (D) indicates that this region of the neuroepithelium is 
folded over in the section. Abbreviations: NR, neural retina; OV, optic vesicle; PNR, 
presumptive neural retina; PRPE, presumptive retinal pigmented epithelium; RPE, 
retinal pigmented epithelium. Scale bar: 100 µm; (P) is representative for (A-P).
                                                                                                                                                       67
                                                                                                                                                       68
Figure 2.12. (Additional file 2) Cell death is not altered in the Ccnd1-/- retina during 
embryonic development. Sections from (A-D) wild-type (wt) and (E-H) Ccnd1-/- retinas 
were stained with an antibody against activated-CASPASE 3, a marker of dying cells. 
No differences were observed in the pattern or number of immunoreactive cells at E12, 
E14.5, or E17.5. At P0, Ccnd1-/- retinas showed a slight increase in the number of 
activated CASP3+ cells. Bright dots in (D) are non-specific background staining. Scale 
bars: 100 µm; (G) is representative for (A, C, E, G); (H) for (B, D, F, H).
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Figure 2.13. (Additional file 3) Phosphorylated histone H3 immunoreactivity. 
Expression patterns of pHH3 at (A, D) E12, (B, E) E14.5, and (C, F) P0 in wild-type 
(wt) (A-C) and Ccnd1-/- retinas (D-F) are shown. Scale bars: 100 µm; (D) is 
representative for (A, D); (F) for (B, C, E, F).
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Figure 2.14. (Additional file 4) Co-expression patterns of retinal progenitor cell 
markers are maintained in the Ccnd1-/- retina. (A-D) Expression patterns of VSX2 
and HES1 at E12 (A, B) and P0 (C, D) in wild-type (wt) retinas are shown. (E-H) 
Expression patterns of VSX2 and HES1 at E12 (E, F) and P0 (G, H) in Ccnd1-/- retinas 
are shown. (I-N) Co-expression patterns of PCNA and VSX2 at P0 in wild-type (I-K) 
and Ccnd1-/- retinas (L-N) are shown. (O-T) Co-expression patterns of PCNA and HES1 
at P0 in wild-type (O-Q) and Ccnd1-/- retinas (R-T) are shown. Note that in all cases the 
co-expression relationships are maintained, indicating that the altered expression patterns 
in the Ccnd1-/- retina are due to the decrease in retinal progenitor cell numbers and not to 
direct regulation of the marker proteins. Abbreviations: NR, neural retina. Scale bars: 
100 µm; (H) is representative for (A-H); (T) for (I-T).
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Figure 2.15 (Additional file 5) Co-expression patterns of PCNA and OTX2 in 
Ccnd1-/-, Ccnd1D2/D2, and Ccnd1hE/hE retinas at P0. (A-R) Ccnd1-/- (D-F), Ccnd1D2/
D2 (J-L) and Ccnd1hE/hE (P-R) retinas and their respective wild type controls ((A-C), 
(G-I), and (M-O), respectively) at P0 were double-labeled with antibodies against 
PCNA and OTX2 Merged images show that OTX2-expressing cells completely fill the 
PCNA- 'gap' in the Ccnd1-/- and Ccnd1D2/D2 retinas (F, L). Abbreviations: DCL, 
differentiated cell layer; NBL, neuroblast layer; PRL, photoreceptor cell layer; RPE, 
retinal pigmented epithelium. Scale bar: 100 µm; (R) is representative for all panels.
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Figure 2.16. (Additional file 6) Expression patterns of POU4F2, PTF1A, SOX2, and 
BHLHB5 in Ccnd1D2/D2 and Ccnd1hE/hE retinas at P0. POU4F2 expression in (A, I) 
wild-type (wt) controls, (E) Ccnd1D2/D2 and (M) Ccnd1hE/hE retina at P0, is shown. 
PTF1A expression in (B, J) wild-type controls, (F) Ccnd1D2/D2 and (N) Ccnd1hE/hE 
retina at P0 is shown. SOX2 expression in (C, K) wild-type controls, (G) Ccnd1D2/D2 
and (O) Ccnd1hE/hE retina at P0 is shown. BHLHB5 expression in (D, L) wild-type 
controls, (H) Ccnd1D2/D2 and (P) Ccnd1hE/hE retina at P0 is also shown. Abbreviations: 
NR, neural retina. Scale bar: 100 µm; (P) is representative for all panels.
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Figure 2.17. (Additional file 7) Expression patterns of PCNA, POU4F2, NEFM, 
PTF1A, SOX2, and BHLHB5 in wild type (Ccnd1+/-), Ccnd1-/- single null, p27Kip1-/- 
single null, and Ccnd1-/-, p27Kip1-/-double null retinas at P0. (A, G, M, S) PCNA 
expression in retinal progenitor cells, showing absence of a significant apical gap in the 
Ccnd1-/-, p27Kip1-/- double null (S) compared to Ccnd1-/- (G). The distributions of (B, H, 
N, T) POU4F2+ retinal ganglion cells, (C, I, O, U) NEFM+ horizontal cells in the outer 
neuroblast layer, (D, J, P, V) PTF1A+, (E, K, Q, W) SOX2+ and (F, L, R, X) BHLHB5+ 
precursors in the double null (bottom row) are more similar to wild type (top row) than to 
the Ccnd1-/-(second row). Expression patterns for each of the markers in the p27Kip1-/- 
retina (third row) are shown for comparison. Scale bar: 100 µm; (X) is representative for 
all panels.





CYCLIN D1 and CYCLIN D3 HAVE NONOVERLAPPING REQUIREMENTS 















The cell cycle regulator Cyclin D1 (Ccnd1) is expressed in embryonic retinal 
progenitor cells (RPCs) and regulates their cell cycle kinetics and neurogenic output. In 
this study, we report that Ccnd1 also has important functions in postnatal retinal 
histogenesis. Early production of Müller glia and bipolar cells was enhanced in Ccnd1-/- 
retinas, indicating a role for Ccnd1 in controlling the timing of generation of these late 
born cell types. Surprisingly, despite a steeper rate of depletion of the RPC population 
throughout the neurogenic interval, Ccnd1-/- retinas exhibited an extended window of 
proliferation, neurogenesis, and gliogenesis. Cyclin D3 (Ccnd3), normally seen in Müller 
glia, was prematurely expressed in Ccnd1-/- RPCs. However, despite this early 
expression, Ccnd3 did not compensate for Ccnd1's role in regulating cell cycle kinetics or 
neurogenic output. The data presented in this study, along with our previous finding that 
Cyclin D2 was unable to fully compensate for Ccnd1, indicate that Ccnd1 has essential 




During the course of mammalian retinal histogenesis, retinal progenitor cells 
(RPCs) proliferate extensively and concomitantly give rise to the six major classes of 
retinal neurons and Müller glia in a temporal order (Livesey and Cepko, 2001; Rapaport 
et al., 2004). Controlled progression through the cell cycle is central for this to occur 
(Bilitou and Ohnuma, 2010; Ohnuma and Harris, 2003). Once committed to undergo cell 
division, an RPC can produce two RPCs, two postmitotic precursor cells, or an RPC and 
a precursor. Since several cell types (i.e. rod photoreceptors, bipolar interneurons, and 
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Müller glia) are produced during the latter half of the histogenic interval, proper 
regulation of the RPC or precursor fate choice in each cell cycle is essential to retain 
enough RPCs for generating the later born cell types. A combination of extrinsic 
signaling pathways and intrinsic fate-determining networks are likely to influence the cell 
cycle machinery, inducing cell cycle reentry (S phase commitment) for RPC-fated cells 
and cell cycle exit for neuronal or glial precursor-fated cells (Andreazzoli, 2009; 
Cayouette et al., 2006; Livesey and Cepko, 2001; Ohnuma and Harris, 2003). 
The three D-type cyclins, Cyclin D1, D2, and D3, are important for the 
transmission of extracellular growth signals to the core cell cycle machinery, facilitating 
progression from G1 into S (Sherr, 1995a; Sherr, 1995b). Previously 
considered universally important for proper development and survival, D-cyclins were 
found to be dispensable for many aspects of development (Kozar et al., 2004; Sherr and 
Roberts, 2004). This is in part due to their selective and dynamic expression in specific 
tissue compartments, and to functional redundancy and compensation in some instances 
(Ciemerych et al., 2002; Kozar and Sicinski, 2005; Kozar et al., 2004). However, cell 
proliferation and a good portion of embryogenesis still occurs in animals lacking all three 
D-cyclins (Kozar et al., 2004). A similar phenomenon has also been observed in mice 
lacking other key cell cycle regulators such as the E-cyclins and most impressively in 
CDK4, CDK6, CDK2 triple knockouts (Geng et al., 2003; Santamaria et al., 2007). A 
current model based on these observations is that molecular adaptation takes place (i.e. 
CDK1 substitutes for the missing Cdks in the triple knockout) (Santamaria et al., 2007). 
In light of these findings, it is reasonable to question the complexity of the mammalian 
cell cycle and what advantages are conferred upon the organism by retaining it, especially 
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when many cell cycle proteins are oncogenes or tumor suppressors, and drive tumor 
formation when mutated or misregulated. One potential way to get at this question is to 
better understand how inactivation of these cell cycle genes alter histogenesis in tissues 
like the retina, where proliferation must be balanced with precursor production. 
Ccnd1 is the predominant D-cyclin expressed in RPCs during retinal histogenesis and 
Ccnd1 knockout (Ccnd1-/-) mice have hypocellular retinas (Das et al., 2009; Fantl et al., 
1995; Ma et al., 1998; Sicinski et al., 1995). We recently demonstrated that Ccnd1 
inactivation increases the cell cycle time in embryonic and neonatal RPCs and enhances 
their rate of cell cycle exit (Das et al., 2009). As a consequence, the RPC population 
undergoes a faster rate of depletion. We also found that, in the absence of Ccnd1, the 
proportions of neuronal precursor populations were changed due to their altered 
production, underlining the importance of CCND1 in generating the correct complement 
of retinal neurons (Das et al., 2009).  
Besides CCND1, the other D-cyclin expressed in the retina is CCND3 (Dyer and 
Cepko, 2000). CCND3 is not usually expressed in RPCs during development. Rather, 
towards the end of histogenesis, it is expressed in newly generated Müller glia precursors 
and possibly in some RPC that give rise to glial cells ((Dyer and Cepko, 2000); see 
below). Western blot analysis of P1 Ccnd1-/- retinas revealed that CCND3 is precociously 
expressed in the mutant, raising the possibility that CCND3 could be compensating for 
CCND1 (Tong and Pollard, 2001).  
In this study, we characterize the effects of Ccnd1 inactivation on postnatal retinal 
histogenesis and determine whether CCND3 is compensatory for CCND1. In spite of the 
smaller RPC population at birth in Ccnd1-/- retinas, generation of postnatal cell types still 
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occurred, although with altered timing. Unexpectedly, the histogenic period is extended 
in Ccnd1-/- retinas, further underscoring the importance of CCND1 in regulating RPC 
proliferation dynamics. We also found that CCND3 does not compensate for CCND1 
loss, at least up until birth. We propose that while D-cyclins and other cell cycle 
regulators are not absolutely required for cell proliferation or tissue histogenesis, the 
diversity of cell cycle proteins and complexity of the cell cycle is maintained in part 
because of nonoverlapping functions of specific cell cycle proteins and a dependence of 
progenitor populations on these proteins to properly time and coordinate proliferation 




Proliferation persists late in Ccnd1-/- retina development  
Due to premature cell cycle exit and a lengthening of cell cycle time, 
RPCs undergo a steeper rate of depletion compared to their wild type counterparts (Das et 
al., 2009). Therefore, we expected proliferation and neurogenesis to terminate 
prematurely in Ccnd1-/- retinas during postnatal development. Before verifying if this was 
true, we first established the normal expression of CCND1 protein from postnatal day 
zero (P0) to P14 (Fig 3.1A-D) in wild type retinas. During this period, CCND1 was 
expressed in RPCs and its pattern matched the expected RPC depletion pattern associated 
with the completion of histogenesis. By P6, CCND1 expression was restricted to almost a 
single row of cells in the central retina (arrows; Fig 1C). Due to the central to peripheral 
progression of retinal histogenesis, many CCND1 expressing cells were still seen in the 
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peripheral retina (data not shown). By P14, CCND1 expressing cells were no longer 
observed in the central (Fig 3.1D) or peripheral retina (data not shown).  
To determine if the RPC population was depleted earlier in Ccnd1-/- retinas, we 
analyzed wild type and Ccnd1-/- retinas at P6 for PCNA expression, a comprehensive 
marker of RPCs (Barton and Levine, 2008). At this age, a large number of PCNA 
expressing cells were present in the peripheral wild type retina (Fig 3.1E). In comparable 
areas of the mutant retina, the PCNA expressing RPC layer was thinner (Fig 3.1I). That 
proliferation was overall reduced in peripheral regions of Ccnd1-/- retinas was further 
corroborated by the presence of fewer PCNA+ cells at the apical surface where mitosis 
occurs (arrows; Fig 3.1E and I) and fewer EdU+ cells (Fig 3.1F and J). In the wild type 
central retina, the few cells that expressed PCNA did so at reduced levels (Fig 3.1G). 
Since EdU labeled cells were not detected in this region (Fig 3.1H), the low level of 
PCNA expression (Fig 3.1G) is not likely to correspond to active proliferation. 
Surprisingly, bright PCNA expressing cells were detected in the Ccnd1-/- central retina 
with some PCNA+ cells undergoing mitosis (Fig 3.1K; arrows point to mitotic figures). 
EdU labeled cells were also detected in this region (arrowheads in Fig 3.1L). 
In sum, although there are fewer proliferating cells in the peripheral regions of the 
mutant retina consistent with a faster rate of RPC depletion, there also exists a population 
of proliferative cells that persists beyond the normal histogenic interval in the central 
retina. This unexpected change in proliferation dynamics is further demonstrated in low 






CCND3 expression initiates earlier in the Ccnd1-/- retina in RPCs,  
but does not affect cell cycle rate or precursor cell type output  
In other tissues, loss of a D-cyclin can be compensated by ectopic or precocious 
expression of the other D-cyclins (Ciemerych et al., 2002; Cooper et al., 2006; Glickstein 
et al., 2007; Lam et al., 2000; Solvason et al., 2000). In neonatal Ccnd1-/- retinas, western 
blots showed that CCND3 protein was precociously expressed (Tong and Pollard, 2001). 
Thus, it seemed possible that CCND3 may compensate for the absence of CCND1 in 
promoting proliferation.  
First, we determined the expression pattern of CCND3 at P0, P4, P6, and P14 (Fig 
3.2A-H). In wild type retinas, CCND3 expression was not observed until P6 (Fig 3.2A-
C), where it was principally seen in the INL and in scattered cells in the ONL (Fig 3.2C; 
arrowheads). CCND3 expression was absent from the peripheral retina, indicating that its 
onset of expression occurs in a central to peripheral fashion and is likely the result of the 
wave of Muller glia genesis . Interestingly, the central to peripheral pattern of CCND3 
expression is coincident with the disappearance of CCND1 along the same gradient, with 
a few cells expressing both proteins at the overlapping expression boundaries (data not 
shown). Together, this suggested a developmental change in utilization of D-cyclins from 
CCND1 to CCND3. At P14, CCND3 is expressed in a single row of cells in the INL (Fig 
3.2D), which was previously shown to be Müller glia (Dyer and Cepko, 2000; Vazquez-
Chona et al., 2009).  
In contrast, we detected CCND3 expression in the neuroblast layer of Ccnd1-/- 
retinas from E17.5 onward (Fig 3.2E,F; data not shown). Colocalization with VSX2 
(Belecky-Adams et al., 1997; Chen and Cepko, 2000; Green et al., 2003; Liu et al., 1994) 
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suggested that CCND3 was expressed in Ccnd1-/- RPCs but not in all phases of the cell 
cycle as indicated by the lack of CCND3 and pHH3 co-labeling (data not shown). By P6, 
CCND3 was expressed strongly in the ONL and INL in a bilayer type pattern. The 
CCND3+ ONL cells were often seen displaced towards dysplastic regions of the ONL 
that were associated with extensive photoreceptor cell death (Ma et al., 1998) (arrow; Fig 
3.2G). Unlike wild type, in the mutant retina, CCND3 was expressed uniformly from 
center to periphery at P6, with the bilayer appearance evident centrally (data not shown). 
By P14, the bilayer pattern of CCND3+ cells extended peripherally and these cells co-
labeled with markers of mature Müller glia (Fig 3.2H; data not shown).   
To determine whether CCND3 was compensating for the loss of CCND1, we 
generated Ccnd1-/-, Ccnd3-/- double knockout (DKO) animals by crossing the two single 
null strains (Fantl et al., 1995; Sicinska et al., 2003; Sicinski et al., 1995). Due to the  
high mortality rate of DKO neonates (Ciemerych et al., 2002), we analyzed the potential 
compensatory effect of CCND3 on RPC proliferation and precursor output at P0. 
We previously reported that the average cell cycle time of Ccnd1-/- RPCs was 
extended (Das et al., 2009). Therefore, if CCND3 had a role in regulating the cell cycle 
rate of Ccnd1-/- RPCs, the average cell cycle time of DKO RPCs would be further 
increased. To test this hypothesis, we sequentially cultured retinas with BrdU and EdU 
from P0 Ccnd1-/- and DKO animals (see Methods). Frozen sections from these cultured 
retinas were labeled with anti-PCNA to identify RPCs, anti-BrdU antibody to detect 
BrdU (and EdU), and with a fluroscently tagged-azide to detect EdU through click-iT 
reaction. The PCNA expression pattern was identical in DKO and Ccnd1-/- retinas (Fig 
3.3A and D) and quantification of PCNA+ cells showed that the proportion of RPCs did 
 85 
not change (data not shown). Determination of average cell cycle time (Tc) of the Ccnd1-/- 
and DKO RPC  population  did not show any significant difference between the two 
groups either (Fig 3G). Similar results were obtained for S-phase time (Ts), cumulative 
G1+G2 +M phase time (Tc-Ts), and percent S-phase (Ts/Tc) measurements (Fig 
3.3G). These data indicate that CCND3 did not influence RPC cell cycle rate, despite its 
precocious expression in Ccnd1-/- retinas. 
Next, we wanted to determine if CCND3 influenced the proportions of neuronal 
precursor cells in Ccnd1-/- retinas. Because CCND3 expression appeared in Ccnd1-/- 
retinas sometime between E14.5 and E17.5 (data not shown), we did not anticipate 
changes in early retinal cell type precursors in the DKO retina. Indeed, expression of 
retinal ganglion cell precursor marker POU4F2 (Gan et al., 1999; Qiu et al., 2008) (Fig 
3.4A and E), horizontal/amacrine cell precursor marker PTF1A (Fujitani et al., 2006; 
Nakhai et al., 2007) (Fig 3.4B and F), and cone photoreceptor cell precursor marker 
RXRγ (Mori et al., 2001) (Fig 4C and G) were not different between the two mutants. 
Further, we did not detect changes in the expression of NR2E3, a precursor marker for 
rod photoreceptors (Bumsted O'Brien et al., 2004; Chen et al., 2005) (Fig 3.4D and H). 
Thus, CCND3 does not appear to regulate early or late precursor production from Ccnd1-
/- RPCs, at least up to P0. 
 
 
CCND1 inactivation alters the production of Müller glia and bipolar cells  
Since CCND3 is normally expressed in Müller glia, the early expression of 
CCND3 in Ccnd1-/- retinas could signify an earlier onset or enhancement in gliogenesis. 
Having observed a robust number of Müller glia in adult Ccnd1-/- retinas (Fig 3.2H) (Ma 
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et al., 1998), we performed birthdating assays to determine if Müller glial cells were born 
earlier. Pregnant dams were injected at E18.5 with EdU and retinas were harvested from 
pups at P14 and examined for evidence of EdU+ Müller glia (schema; Fig 3.5). RPCs that 
exited the cell cycle soon after EdU incorporation are predicted to retain most of the label 
and appear as the 'brightest' EdU+ cells (EdUhigh). In both wild type and Ccnd1-/- retina 
sections, we observed EdU+ cells of varying brightness (Fig 3.5A and D). In the central 
wild type retina, most of the EdUhigh cells were in the ONL, consistent with rod 
photoreceptor production. A few EdUhigh, SOX9+ (Poche et al., 2008) double labeled cells 
were detected in the INL (normal arrow; Fig 3.5A-C, inset box C' in Fig 3.5C), but most 
of the double labeled cells exhibited weak EdU labeling (EdUlow), suggesting that more 
than one cell cycle passed before exit (hollow-head arrows in Fig 3.5A-C, inset box C'' in 
Fig 3.5C). All SOX9+ cells, regardless of the intensity of EdU detection, expressed 
Glutamine Synthetase (GS), a marker of Müller glia (Vardimon et al., 1986) (normal 
arrow in Fig 3.5C' and hollow-head arrows in Fig 3.5C''). In contrast, Ccnd1-/- retinas 
showed a higher occurrence of EdUhigh, SOX9+ cells (normal arrow in Fig 3.5D-F, inset 
boxes F' and F'' in Fig 3.5F) and a lower incidence of EdUlow, SOX9+ cells (hollow-head 
arrow in Fig 3.5D-F, inset box F'' in Fig 3.5F). As in the wild type, all the double labeled 
cells expressed GS, confirming their identity as Müller glia (normal arrows in Fig 3.5F' 
and F'' and hollow-head arrow in Fig 3.5F''). These data suggest that the rate of Müller 
glia production was enhanced in the absence of CCND1.  
We also birthdated bipolar cells at the same age using the identical protocol and 
observed more EdUhigh cells expressing VSX2 (Burmeister et al., 1996; Green et al., 
2003) or PKCalpha (Greferath et al., 1990) in the mutant retinas than in comparable areas 
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of wild type (data not shown). These data suggest that the general program of late retinal 
histogenesis was accelerated in the Ccnd1-/- mutant. 
 
 
Late proliferating cells in Ccnd1-/- retinas exhibit RPC-like properties 
The persistent proliferation in the postnatal Ccnd1-/- central retina was unexpected 
because of the increased rate of RPC depletion. However, since apoptosis is increased 
postnatally and especially in the ONL (Ma et al., 1998), it is possible that the Müller glia 
re-entered the cell cycle, a phenomenon observed in several instances of retinal injury 
and disease (Dyer and Cepko, 2000; Fischer and Reh, 2003; Karl et al., 2008; Kohno et 
al., 2006; Tackenberg et al., 2009; Thummel et al., 2008). It is also possible that the 
proliferating cells were RPCs that persisted longer, potentially due to the slower rate of 
cell cycle progression. Distinguishing between Müller glia and RPCs is difficult because 
their gene expression profiles are remarkably similar (Roesch et al., 2008). However, 
proliferative Müller glia typically adopt a reactive phenotype, which among other criteria, 
is associated with elevated GFAP expression, a protein not found in RPCs (Humphrey et 
al., 1997; Sahel et al., 1990; Taomoto et al., 1998). Furthermore, RPCs would be 
expected to produce both neurons and glia given their mulitpotential character, a property 
not normally observed in mammalian Müller glia (Jadhav et al., 2009; Karl and Reh, 
2010). 
Based on these operational criteria, we sought to determine the identity of the 
proliferating cells by examining GFAP expression and by a birthdating assay in which P6 
pups were injected with EdU and analyzed for neuronal and glial marker expression at 
P14 (schema; Fig 3.6). We did not observe GFAP expression at P6 or any marker for glia 
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maturation (data not shown) at P8. At P14, GFAP expression was mostly confined to 
regions of focal photoreceptor degeneration (data not shown). In contrast to the wild type 
retina, which contained EdU+ cells only in the peripheral retina, EdU+ cells were found in 
both central and peripheral mutant retina (Fig 3.6A and B). Importantly, PCNA was not 
expressed centrally, indicating that the EdU+ cells were no longer proliferating (data not 
shown). Some EdU+ cells were found to be  SOX9+ and GS+, identifying them as Müller 
glia (Fig 3.6C-F; open arrows) whereas others were SOX9 and GS negative (Fig 3.6C-F; 
closed arrows). Consistent with the latter cohort, some EdU+ cells were VSX2+, PKCA-, 
which are presumptive cone bipolar cells (Fig 3.6G-J; double headed arrow), VSX2+, 
PKCA+, identifying them as rod bipolar cells (Fig 6G-J; arrowhead). Rare EdU+ cells 
were also RCVRN+ in the ONL indicative of photoreceptors (Fig 3.6K-M; open arrow). 
These observations suggested that the late proliferating cells in Ccnd1-/- retinas, being 
capable of both neurogenesis and gliogenesis, were more likely to be RPCs or cells 




Altered histogenesis in Ccnd1-/- retinas 
A novel finding of our study was that CCND1 inactivation resulted in the 
persistence of proliferating cells beyond the normal period of RPC proliferation. This was 
unexpected because the Ccnd1-/- RPC population has a steeper rate of depletion during 
embryonic development (Das et al., 2009). Indeed, in the postnatal peripheral retina, 
where proliferation was still ongoing in wild type, comparable areas of the Ccnd1-/-
 retinas were visibly deficient in RPCs and proliferation, consistent with premature cell 
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cycle exit. But in the central retina, histogenesis, although terminated in the wild type, 
was still evident in the mutant. 
One explanation for the latter observation is that CCND1, in reversal to its' 
embryonic role, promotes cell cycle exit during postnatal histogenesis. This is highly 
unlikely, however, given that it is an oncogene and its expression generally promotes cell 
cycle progression (Liao et al., 2007; Motokura and Arnold, 1993; Sherr, 1995a). For 
example, CCND1 overexpression in the developing telencephalon enhanced proliferation, 
due in large part to shortening the duration of G1, and CCND1 RNAi produced the 
opposite result (Lange et al., 2009; Pilaz et al., 2009). Rather, a more plausible 
explanation is that RPCs persist in the mutant because of the slower cell cycle rate, and 
that they continue to proliferate until they reach a certain number of cell cycles or until 
the extracellular environment no longer supports their proliferation (Fig 3.7). This may 
appear to be at odds with our previous findings that Ccnd1-/- RPCs undergo premature 
cell cycle exit and that CCND1 is expressed in the vast majority of RPCs (Barton and 
Levine, 2008; Das et al., 2009). But since the faster depletion rate in the mutant is not 
severe, it appears that CCND1 influences the timing of cell cycle exit in a small subset of 
RPCs with limited proliferative potential at any given stage of histogenesis (Das et al., 
2009). This restricted mode of exit control, combined with the slower cell cycle rate, 
could allow for an extended proliferative period. Whether all RPCs ultimately pass 
through a CCND1-dependent phase to control their timing of cell cycle exit is still an 
open question. 
Our P6 birthdating experiments showed that the late proliferating cells were 
capable of producing both late-born retinal neurons and Müller glia and suggest that these 
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cells could be bona-fide RPCs, consistent with the idea of extended histogenesis. 
However, we can not exclude the possibilities that proliferating Müller glia are 
intermingled with RPCs or that the dividing cells are not true RPCs but are neurogenic 
Müller glia, of which there is evidence in other vertebrates and under certain 
experimental conditions (Fischer and Reh, 2003; Jadhav et al., 2009; Karl and Reh, 
2010). The likelihood that some of these cells are proliferating Müller glia is low because 
we did not detect GFAP expression until several days after P6 and many studies indicate 
that proliferating Müller glia express GFAP as part of their progression into a reactive 
state (Humphrey et al., 1997; Sahel et al., 1990; Taomoto et al., 1998).  Distinguishing 
between neurogenic Müller glia and RPCs is difficult because there may be little 
difference between them other than the cell of origin (Roesch et al., 2008). However, if 
these neurogenic progenitors do arise from Müller glia, it suggests that preventing the 
reactivity in otherwise proliferative Müller glia may enhance their neurogenic potential. 
We also observed that CCND3 express came on in the Ccnd1-/- RPCs prematurely. 
Interestingly, this early expression of CCND3 was abrogated in mice models where loss 
of Ccnd1 was rescued to various degrees. Thus, CCND3 expression was not observed in 
P0 retinas from Ccnd1-/-, p27Kip1-/- double mutant (Geng et al., 2001; Tong and Pollard, 
2001) and mouse strains containing the Ccnd2 cDNA targeted to the Ccnd1 locus 
(Ccnd1D2/D2) (Carthon et al., 2005) and human Ccne cDNA targeted to the Ccnd1 locus 
(Ccnd1hE/hE) (Geng et al., 1999) ( data not shown). This argues against a direct 
transcriptional or post-translational control of CCND3 by CCND1, and instead suggests 
that premature CCND3 expression may be a manifestation of an accelerated 
developmental program in Ccnd1-/- retinas. This is somewhat supported by our current 
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observations that the initial production of  Müller glia, a cell type associated with 
CCND3 expression, and bipolar cells is heightened in the mutant retina (Fig 3.5 and data 
not shown). Further, it seems that photoreceptor precursor cells mature faster in Ccnd1-/- 
retinas and show earlier than normal expression of RCVRN, a photoreceptor maturity 
marker (Sharma et al., 2003), at E17.5 (G.D and E.M.L unpublished observations). 
However, adult Ccnd3-/- retinas look perfectly identical to wild type, with normal 
numbers of glia cells. Also, CCND3 does not seem to be required for Müller glia 
response in certain retinal injury models (G.D, E.M.L, and F.V.Z unpublished 
observations). This indicates that CCND3 is not required for glia formation or function, 
at least at our level of analysis. It further suggests that the increased production of glia 
and bipolar cells observed in Ccnd1-/- retinas may not be a consequence of the early 
activation of CCND3, but rather a direct result of Ccnd1 deficiency. 
 
 
Lack of compensation among D-cyclins in retinal development 
In other developing tissues, loss of one D-cyclin often results in the upregulation 
of another compensating D-cyclin (Ciemerych et al., 2002; Cooper et al., 2006; 
Glickstein et al., 2007; Lam et al., 2000; Satyanarayana and Kaldis, 2009). Although 
CCND3 is precociously expressed in Ccnd1-/- retinas, it did not have any measureable 
effects on RPC cell cycle rate or precursor production, suggesting that CCND3 does not 
compensate for CCND1. Further, reports indicate that Ccnd1-/-, Ccnd3-/- knockout RPCs 
do not see upregulation of Ccnd2 and that proliferation of  Ccnd1-/-, Ccnd2-/-, Ccnd3-/-
 triple knockout RPCs were similar to Ccnd1-/- null RPCs (Ciemerych et al., 2002; Kozar 
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et al., 2004). These observations argue against potential compensation by CCND2 
in Ccnd1-/-, Ccnd3-/- mutants.  
While CCND3 is expressed in neonatal RPCs, it differs from CCND1 in that it is 
not expressed in all RPCs. This could explain CCND3's failure to compensate for 
CCND1. However, we also found that CCND2 did not completely restore retinal 
development when expressed from the CCND1 locus (Das et al., 2009). It is therefore 
possible that in addition to potential differences in expression, the failure of CCND3 and 
CCND2 to compensate for the CCND1 deficiency is because CCND1 has functions not 
shared by the other D-cyclins. However, it would require knocking-in of Ccnd3 to 
replace Ccnd1 expression from its' genomic locus, to conclusively validate whether 
CCND3 could functionally replace CCND1. 
 
 
Summary and significance 
We studied the role of D-cyclins during postnatal retina development. We found 
that CCND1 was also required for proper postnatal development of the mouse retina. 
Unexpectedly, we showed that proliferation persisted in Ccnd1-/- retinas even after 
normal termination of proliferation in wild type. One possibility we outline is that the 
extended proliferation is a result of gradually extended cell cycle time in mutant RPCs 
(Fig 3.7). Potentially, injecting cell cycle slowing factors to wild type retinas or cell cycle 
accelerating factors to postnatal Ccnd1-/- retinas can determine whether regulation of cell 
cycle time is responsible for this phenomenon. Along with our earlier study on CCND1's 
role during embryonic retinogenesis (Das et al., 2009), this current study highlights two 
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roles for CCND1 during mammalian retina development: a) to prevent cell cycle exit in a 
limited set of RPCs and b) to regulate proper cell cycle length in RPCs.  
Our work supports the idea that although a D-cyclin like CCND1 may be 
expressed globally in a tissue compartment, its requirement is restricted to a currently 
undefined subset of proliferating cells. Our model predicts that, at least in the developing 
retina and maybe even more globally, this limited subset of proliferating cells is restricted 
in their proliferative potential, producing upon mitosis a daughter progenitor cell that 
requires CCND1 to commit to at least another round of mitosis before terminal division. 
 
 
Materials and methods 
Animals  
Ccnd1-/- mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA). 
Ccnd3-/- mice were kindly provided by Dr. Iannis Aifantis (New York University Medical 
Center, NY) and p27Kip1-/- mice by Drs. James Roberts and Matthew Fero (Fred 
Hutchinson Cancer Center, Seattle, WA). The noon of the day a vaginal plug was 
observed was designated E0.5. Genotyping was done as previously described (Fero et al., 
1996; Sicinska et al., 2003; Sicinski et al., 1995). All animal use and care was conducted 
in accordance with protocols approved by the University of Utah Institutional Animal 
Care and Use Committee and set forth in the Association for Research in Vision and 
Ophthalmology (ARVO) Statement for the Use of Animals. Efforts were made to 
minimize discomfort to animals and, when possible, the number of animals needed per 




Immunohistochemistry and image analysis  
Tissue preparation and immunohistochemistry were done as previously described 
(Clark et al., 2008; Das et al., 2009). Radial cryosections through the retina were cut at a 
thickness of 10 µm. Primary antibodies are listed in Table 3.1. Sections were analyzed by 
epi-fluorescence using a Nikon E-600 microscope and images captured in gray scale 
mode with a Spot-RT slider CCD camera (Diagnostic Instruments, Sterling Heights, MI, 
USA). Confocal images were scanned using an Olympus Fluoview 1000 microscope. 
Color (RGB) images were assembled from individual monochrome channels using 
Photoshop CS (Adobe Systems Inc., San Jose, CA, USA). The levels function was used 
to adjust the digital images to be consistent with visual observations.  
 
 
Marker quantification and statistical analysis  
The relative proportions of marker-positive (+) cells were quantified at P0. For each 
genotype, a minimum of three animals from at least two litters was sampled. For each 
animal, generally three different areas from non-adjacent central-retina sections were 
used for cell counting. Alternatively, two areas from each section, from opposite sides of 
the optic nerve head from at least two nonadjacent sections, were counted. All cell counts 
were done using Adobe Photoshop CS and ImageJ (NIH). Students’ t-test was performed 
using Kaleidagraph statistical and graphing software (Synergy Software, Reading, PA, 
USA) to determine statistical significance in the marker+ cell population between mutant 
and control samples. Numbers inside bars on all graphs indicate the number of samples 
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analyzed. Error bars represent standard deviation. For further details of cell counting 
protocols refer to (Das et al., 2009).  
Window-labeling using BrdU and EdU to measure cell cycle times  
Retinas with lens attached were cultured for 2.5 hours and sequentially exposed to 
two thymidine analogs for defined intervals. At P0, BrdU was added to the culture 
medium for the first 2 hours and replaced with 5-ethynyl-2′-deoxy-uridine (EdU) for the 
final 30 minutes. A mouse anti-BrdU antibody(clone B44; BD Biosciences, San Jose, 
CA, USA) or rat anti-BrdU antibody(clone BU1/75; Serotec, Raleigh, NC, USA) were 
used to detect the analogs at P0. EdU was specifically detected using the Click-iT  
Reaction (Molecular Probes, Carlsbad, CA, USA) (Buck et al., 2008). PCNA was used to 
identify RPCs in all phases of the cell cycle (Barton and Levine, 2008). For further 
details on how to derive the various parameters of the cell cycle refer to (Das et al., 
2009). Cell counts were done as described in the previous section. A more detailed 
analysis of this assay will appear in a forthcoming manuscript.  
 
 
Neuronal birthdating assay  
Retinal neurons were birthdated by EdU injections at appropriate ages. For late 
embryonic birthdating (E16.5-E18.5), pregnant mice were injected twice, 4 hours apart 
with doses of EdU (10 mM stock in H20: 25 mg/gm of body weight injected; equates to 
10mL/gm body weight to inject). For postnatal birthdating (P6-P10), each individual 
animal was injected with a single dose of EdU (10 mM stock in H20: 50 mg/gm of body 
weight injected; equates to 20mL/gm body weight to inject). All animals were sacrificed 
and retina tissue was harvested at P14.  
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To identify a particular class or type of cell born, soon after the EdU injections, 
sections were co-labeled with Click-iT reaction for EdU detection and antibodies against 
cell type specific marker(s). A cell co-positive for specific marker(s) and EdU (bright 
cells), in all likelihood exited the cell cycle or was born, after a single mitotic division of 
its EdU labeled parent RPC. Because of the importance of identifying varying levels of 
EdU  by fluorescent detection (brightness of the EdU label), all imaging of EdU within a 
particular experimental and control groups, was performed with identical settings and 
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Figure 3.1: Late, unexpected proliferation in developing Ccnd1-/- retinas.  
(A-D) Wild-type retinas were labeled with antibody against CCND1 from P0 to P14. 
CCND1 was expressed in retinal progenitor cells (RPCs) and expressed in the NBL at P0 
and P4 (A and B). Eventually, by P6, expression was restricted to the INL, in more central 
parts of the retina (C). By P14, retinal proliferation was exhausted, reflected in the 
absence of RPCs, and thus CCND1 expression in the retina (D). (E-L) P6 wild type 
and Ccnd1-/- retinas were labeled with antibody against the RPC marker PCNA and were 
pulse-labeled with EdU, 2 1/2 hours before tissue fixation. Representative field from 
peripheral (E, I), and central (G, K) wild type and Ccnd1-/- retinas. Arrows in E, I, and K 
point to PCNA expressing mitotic figures. EdU labeled cells in the peripheral (F, J) and 
central (H, L) wild type and Ccnd1-/- retinas. Arrowheads in (L) point to EdU labeled 
cells in the central mutant retina. (M-N) low power view of peripheral-to-central extent of 
wild type (M) and Ccnd1-/- retinas (N), stained with PCNA antibody. Abbreviations: 
DCL, differentiated cell layer; NBL, neuroblast layer; ONL, outer nuclear layer; OPL, 
outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, 
ganglion cell layer. Scale bars: 100 цm; (D) is representative for (A-D); (K) for (E, G, I 
and K), (L) for (F, H, J, and L) and (N) for (M, N).  
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Figure 3.2: CCND3 was expressed in Ccnd1-/- RPCs early in development, in 
addition to usual latter Müller glia expression.  
(A-H) Wild type and Ccnd1-/- retinas from P0 to P14 were stained with an antibody 
against CCND3. In wild type retinas, CCND3 expression did not occur until P6 (A-C). 
CCND3 expression was restricted to the INL at P6 and beyond (C-D). Arrowheads in (C) 
points to cells expressing low levels of CCND3 in the ONL. CCND3 is expressed earlier 
in Ccnd1-/- retinas (E-F), mainly in the neuroblast layer (NBL). At later stages (G-H; P6 
and P14), CCND3 expressing cells are also found in the ONL of Ccnd1-/- retinas. Arrow 
in G points to an area of focal cell death in the mutant retina. Asterisks in (C, D, G, and 
H) point to blood vessels stained non-specifically by anti-mouse secondary 
antibody. Scale bars: 100 цm; (D) is representative for (A-D); (H) for (E-H).  
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Figure 3.3: Ccnd3 did not regulate cell cycle time of RPCs in Ccnd1-/- retinas. 
(A-F) P0 Ccnd1-/- and Ccnd1-/-, Ccnd3-/- retinas cultured successively in 
Bromodeoxyuridine (BrdU) for 2 hours and 5’-ethynyl-2’ deoxyuridine (EdU) for 30 
minutes. Sections were triple-labeled with an antibody against PCNA marking RPCs (A 
and D), anti-BrdU antibody (Ab) recognizing both BrdU and EdU (B and E) and an 
Alexa dye conjugated azide via click-it reaction, for EdU detection (C and F). Arrows in 
(A-C) mark BrdU+ only RPCs (PCNA+, BrdU+, EdU- ; positive signal in A and B but not 
C) in wild-type retina. Arrows in (D-F) mark similar BrdU+ only RPCs (positive signal in 
D and E but not F) in the Ccnd1-/- retina. (G) Quantification of average RPC cell cycle 
time (Tc), S phase time (Ts), G1 + G2 + M phase time (Tc - Ts) and percent S phase (Ts/
Tc *100) in Ccnd1-/- and Ccnd1-/-, Ccnd3-/- retinas at P0. Numbers inside bars represent 
number of  animals analyzed. Scale bar: 100 цm; (F) is representative for (A-F). Error 
bars represent standard deviation of the mean.
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Figure 3.4: Ccnd3 did not influence precursor cell type output from RPCs in 
Ccnd1-/- retinas.
(A-H) P0 Ccnd1-/- and Ccnd1-/-, Ccnd3-/- retinas were stained with antibodies against 
RGC precursor marker POU4F2 (A and E), horizontal –amacrine precursor marker 
PTF1A (B and F), cone photoreceptor precursor marker RXRɣ (C and G), and rod 
photoreceptor precursor marker NR2E3 (D and H). Abbreviation: NBL, neuroblast layer. 
Scale bar: 100 ɥm; (H) is representative for (A-H). 
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Figure 3.5:Early production of Müller glia cells was enhanced in Ccnd1-/- retinas. 
Retinal cells were 'birth-dated' at E18.5 by injecting pregnant animals with 2 doses of 
EdU, 4Hrs apart and retinas were collected at P14 from the litter. (A-F'') P14 wild type 
and Ccnd1-/- retina sections were triple labeled with click-it reaction for EdU (A and D), 
antibody against Müller glia nuclei marker SOX9 (B and E) and antibody against glia 
maturation marker GS. (C and F) are merged image for EdU and SOX9, and (C', C'', F' 
and F'') merged images for EdU, SOX9 and GS. Normal head arrows point to 'bright' 
EdU+, SOX9+, GS+ triple labeled cells; these cells, most likely, had exited the cell cycle a 
cell division or two after incorporating the EdU label (E18.5), to form glial cells. Hollow 
head arrows point to 'dim' EdU+, SOX9+, GS+ triple labeled cells; these cells probably 
had more than two cell divisions between EdU incorporation and cell cycle 
exit. Abbreviations: DCL, differentiated cell layer; NBL, neuroblast layer; ONL, outer 
nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform 
layer; GCL, ganglion cell layer. Scale bar in (F) is 100 um and representative for (A-C 
and D-F ); Scale bar in (F'') is 20 um and representative for (C'-C'' and F'-F''). 
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Figure 3.6: Late proliferating cells in Ccnd1-/- retinas were capable of producing both 
Müller glia and retinal neurons.  
Retinal cells were 'birthdated' at P6 by a single EdU injection and retinas were collected 
at P14. (A-B) Low power images of P14 wild type and Ccnd1-/- retina sections showing 
EdU labeled cells. (C-F) Representative central regions of Ccnd1-/- retina sections triple 
labeled for EdU, SOX9 and GS, for identification of Müller glia cells 'born' after the P6 
injection. (F) is a merged image for all three labels. Normal head arrow in (C-F) points to 
a birthdated non-glia cell (EdU+, SOX9-, GS-). Open head arrows in (C-F) point to a 
birthdated Müller glia cell (EdU+, SOX9+, GS+). (G-J) Representative central regions 
of Ccnd1-/- retina sections tripled labeled for EdU detection, pan-bipolar marker VSX2 
and rod bipolar marker PKCA, for identification of cone and rod bipolar cells 'born' after 
the injection. (J) is a merged image. Double head arrows in (G-J) point to a birthdated 
cone bipolar cell (EdU+, VSX2+, PKCA-). Arrow heads in (G-J) point to a birthdated rod 
bipolar cell (EdU+, VSX2+, PKCA+). (K-M) P14 central retina section double-labeled for 
EdU and general photoreceptor cell marker RCVRN, for birthdating photoreceptor cells 
'born' after the injection at P6. Hollow head arrows in (K-M) point to a birthdated 
photoreceptor cell (EdU+, RCVRN+).  Abbreviations: DCL, differentiated cell layer; 
NBL, neuroblast layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner 
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar in (B) is 
100 um and representative for (A-B); Scale bars in (J and M) are 20 um; (J) is 
representative for (C-J) and (M) is representative for (K-M).  
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Figure 3.7: Model: lengthening cell cycle can lead to extended proliferation, 
neurogenesis and gliogenesis in Ccnd1-/- retinas 
A speculative model as to how increased cell cycle time in Ccnd1-/- retinas can lead to 
extended retinal histogenesis. A set of RPCs restricted in their proliferative potential 
depends on CCND1 to stay in the cell cycle (dark gray box in wild type). Without it, a 
Ccnd1 null RPC that would normally divide again, now prematurely exits from the cell 
cycle to  adopt a precursor fate (asterisk marked cells in wild type and Ccnd1-/- ). A larger 
set of RPCs is probably dependent on CCND1 to maintain cell cycle time (light gray 
boxes in wild type and Ccnd1-/- ). Without CCND1, the cell cycle time of mutant RPCs, 
becomes inappropriately lengthened. These RPCs, not being dependent on CCND1 to 
stay in the cell cycle, spend a longer time in the cell cycle, and as a result linger in the 
mutant retina. They eventually exit from the cell cycle to make neurons and glia, even 
after neurogenesis has ceased in the wild type retina.  








































































CCND1 regulates cell cycle time of RPCs 
Our studies find that without CCND1, the cell cycle time of mutant RPCs is 
lengthened compared to that of wild type controls and this is probably caused by an 
increase in G1 phase time. A role for CCND1 and other D-cyclins in controlling the 
length or time of G1 is supported by studies in other systems as well. Proliferating mouse 
embryonic fibroblast (MEF) cells from Ccnd1-/-, Ccnd2-/-, Ccnd3-/- triple knockout mice 
exhibited an increased proportion of cells in G1, and a decreased proportion of cells in S-
phase, indicating that cells spend a longer time in G1 (Kozar et al., 2004). Conversely, 
overexpression of D-cyclins shortened G1 phase time in MEF cells (Quelle et al., 1993). 
During mouse cortical neurogenesis, Ccnd1 knockdown in neural progenitors by in vivo 
RNAi resulted in an elongated G1 phase (Lange et al., 2009; Pilaz et al., 2009). 
Conversely, overexpression of CCND1 in these progenitors led to a shortened G1 (Lange 
et al., 2009; Pilaz et al., 2009). In cancer models, oncogenes elevate CCND1 levels to 
reduce G1 phase time, and in the process, increase S-phase entry and proliferation 
(Westerheide et al., 2001; Yata et al., 2001). 
The length of G1 also varies significantly during embryonic development. The 
cell cycle during early embryonic development in many organisms have short or almost 
absent G1 phases (Budirahardja and Gonczy, 2009; Ciemerych and Sicinski, 2005). 
These early cell cycles consist only of an S phase for DNA replication and an M phase 
for cell division. They lack both gap phases. Later in murine embryonic development, 
various cell lineages have varying cell cycle kinetics. This variation is caused by 
divergent G1 lengths (Ciemerych and Sicinski, 2005). For example, during gastrulation in 
rat embryos, proliferating cells in the embryonic mesoderm exhibited a cell cycle time of 
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approximately 7 to 7.5 hours. During the same period, proliferating cells in the primitive 
streak underwent mitosis every 3-3.5 hours, and had dramatically reduced G1 and G2 
phases (Mac Auley et al., 1993). Later in development, during organogenesis (for 
instance, during retina formation), the cell cycle structure is similar to the typical M-G1-
S-G2 organization. Further, with the progression of organogenesis, the overall cell cycle 
is gradually lengthened. This results mainly from an increase in G1 phase, although in the 
rat retina, an increase in S phase is also responsible (Alexiades and Cepko, 1996; 
Caviness et al., 1995). 
A parallel situation is observed in murine embryonic stem cells (ESCs), where the 
length of G1 is much shorter than in somatic progenitor cells (Neganova and Lako, 2008; 
Savatier et al., 1994). As these ESCs differentiate into specific lineages, the length of the 
G1 phase undergoes a significant increase (White et al., 2005).  
The change in G1 length with development/differentiation has a direct correlation 
with the status of the retinoblastoma (RB) pathway. In mouse pre-implantation embryos, 
RB expression was initially observed from immature oocytes to the two-cell stage 
(Iwamori et al., 2002; Moore et al., 1996). Subsequently, RB transcript and protein 
expression rapidly disappeared. Expression of RB was re-initiated with the onset of 
differentiation and implantation of the embryo in the late blastocyst stage (Iwamori et al., 
2002). It was observed that the period when RB was absent correlated well with a 
substantially shortened G1 (Moore et al., 1996; Smith and Johnson, 1986). 
In ESCs, RB proteins were held inactive by cell cycle independent kinase activity. 
With subsequent lineage restriction of ESCs, RB functionality was restored (Stead et al., 
2002; White et al., 2005). Together, with the above description of cell cycle kinetics in 
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ESCs (Neganova and Lako, 2008), this implies that absence or inactivity of RB correlates 
with an absent/short G1 phase and that establishment of RB expression or function 
parallels a substantial/longer G1 phase.  
In this light, the mechanism of CCND1 mediated control of G1 phase time 
becomes clearer. CCND1 is an inhibitor of RB function, and a promoter of G1 to S 
progression. In rapidly dividing cells, such as mouse ESCs, CCND1 plays no role in cell 
cycle time maintenance because RB is held inactive by D-cyclin independent 
mechanisms (Stead et al., 2002) and G1 is almost nonexistent. With subsequent 
activation of the RB pathway during lineage restriction, a D-cyclin like CCND1 is 
required to ensure progression into S, and to keep G1 from inappropriately elongating by 
counteracting RB function. In somatic tissues, the central role of the RB pathway in G1 
length/time control was highlighted by the finding that pharmacological inhibition of the 
CyclinE1/Cdk2 complex, another negative regulator of RB activity, resulted in elongated 
G1 (Calegari and Huttner, 2003).  
It is tempting to speculate that CCND1 mediated cell cycle length control may 
have a crucial role in regulating the window of retinal histogenesis. In Chapter 3, it was 
reported that in spite of RPC depletion - due to an increase in their rate of cell cycle exit - 
the period of retinal proliferation and neurogenesis was extended in the Ccnd1 mutant. 
An interesting future experiment would be to speed up RPC cell cycle, for instance, by 
means of CCND1 overexpression, and observe whether retinal histogenesis then 
terminates earlier. Interestingly, retinas deficient for the CDKI, p27Kip1, also had an 
extended proliferative period (Cunningham et al., 2002; Levine et al., 2000). P27KIP1 
acts antagonistically to CCND1 in the retina. Deletion of p27Kip1 rescued many of the 
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defects observed in Ccnd1 null retinas (Das et al., 2009; Geng et al., 2001; Tong and 
Pollard, 2001). Determination of RPC cell cycle kinetics and the period of retinal 
histogenesis, in p27kip1 null and Ccnd1, p27Kip1 double null retinas, can reveal the 
relationship between these two phenomenons. 
 
 
CCND1 prevents premature cell cycle exit of RPCs 
As reported in Chapter 2, Ccnd1 controls the timing of cell cycle exit in RPCs. 
Therefore without CCND1, although a majority of RPCs still undergo cell division, a 
small but significant number of them prematurely withdraw from the cell cycle. This 
increases the rate of RPC cell cycle exit during embryonic development. Findings in 
other experimental systems also support the role of CCND1 in preventing cell cycle exit 
and some of them are briefly described below. 
 In C2C12 myoblast cell line, a positive mediator of cell growth NF-kb inhibited 
myogenic differentiation and induced myoblast proliferation through direct 
transcriptional activation of Ccnd1. Inhibition of NF-kb function led to reduced myoblast 
proliferation and increased cell cycle exit (Guttridge et al., 1999). A protein called 
JUMONJI (jmj) inhibited Ccnd1 by direct transcriptional repression in both cardiac 
myocytes and the hindbrain ventricular zone (VZ) during development. Loss of jmj led to 
hyperproliferation of cardiac myocytes and ectopic proliferation in the hindbrain 
(Takahashi et al., 2007; Toyoda et al., 2003). Deletion of Ccnd1 rescued the aberrant 
phenotypes in both scenarios, indicating a role for Ccnd1 in regulating cell cycle exit 
downstream of jmj (Takahashi et al., 2007; Toyoda et al., 2003). The orphan nuclear 
receptor Tlx is expressed in periventricular neural progenitor cells during embryonic 
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mouse development. It regulates cell cycle kinetics and exit by acting on Ccnd1. In the 
absence of Tlx, CCND1 expression decreased. This resulted in prolonged cell cycle times 
and increased cell cycle exit in the embryonic brain (Toyoda et al., 2003). It becomes 
clear from the above examples that CCND1 is critical for preventing cell cycle exit in 
dividing cells and as discussed in Chapter 2, it likely does so by regulating the 
Retinoblastoma (RB) pathway. 
Although CCND1 is expressed in all RPCs during development, why are only 
small fractions of them sensitive to Ccnd1 loss and exit from the cell cycle prematurely? 
Results from Chapter 3 indicate that this is not due to compensation by Ccnd3; CCND3 
does not seem to be expressed in Ccnd1 null RPCs in the early embryonic retina. CCND3 
was not expressed in Ccnd1 null retinas at E14.5 or before (data not shown). Its 
expression was first observed at E17.5 in the mutant retina. Even at P0 when Ccnd3 
expression was widespread in Ccnd1-/- RPCs, it did not seem to affect either cell cycle 
length or exit (Fig 3.3 and 3.4).  
Before E14.5, CCND1 was expressed robustly in both pre-neurogenic and 
neurogenic RPCs. Although cell cycle kinetics was not directly measured, no apparent 
proliferation defects were observed in the Ccnd1 null pre-neurogenic RPC population. 
After the onset of neurogenesis, premature cell cycle exit of the mutant RPCs led to 
overproduction of ganglion cells (Chapter 2).  
As Ccnd1 is a major regulator of cell cycle progression in G1 and an important 
player in the RB pathway, its requirement may be tied to the setting up of RB protein 
expression and function in retinal cells. Three RB family members, RB1, p107, and p130 
are expressed in the developing mouse retina in a dynamic pattern (Donovan et al., 2006; 
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Spencer et al., 2005). An expression study in the mouse retina reported that none of the 
RB family members were detected by immunohistochemistry in the undifferentiated 
neuroblast layer of the embryonic retina (Spencer et al., 2005). The specific stage, 
however, was not reported and needs to be verified. Nevertheless, this strongly suggests 
that RB factors are not expressed in pre-neurogenic RPCs. This can be a potential 
explanation for why CCND1 is not required in pre-neurogenic RPCs to prevent 
premature cell cycle exit. At E14, P107 is the primary RB protein expressed in 
approximately 60-77% of RPCs (Donovan et al., 2006). These RPCs extinguished P107 
expression as they exited from the cell cycle. However, a short period of P107 expression 
in newly postmitotic precursor was not ruled out from the study (Donovan-Dyer 2004). 
Therefore, the expression of CCND1 in embryonic RPCs most likely overlaps with P107 
expression. CCND1 is probably required to counteract P107 function in cell cycle exit.  
It can be argued that P107 expressing RPCs represent too large a population to be 
the ‘limited RPC-subset’ that depends on CCND1 to prevent premature cell cycle exit. 
However, besides marking the above CCND1-dependent limited subset, the P107 
expression pattern may also reflect its role in regulating cell cycle rate/length in RPCs. 
CCND1 expression may also be required in some or all of these P107 expressing RPCs to 
maintain proper cell cycle kinetics. 
In postnatal stages, RB1 is the primary RB protein expressed in RPCs. Its 
expression persisted in most postmitotic precursors (Spencer et al., 2005; Zhang et al., 
2004). At P5, RB1 expression was seen in most cells of the retina, including a small band 
of cell in the INL, which can be late RPCs (Spencer et al., 2005). RB1 expression also 
persisted in Müller glia cells that arise from the same area in the INL (Spencer et al., 
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2005; Zhang et al., 2004) (Fig 3.2). This pattern of RB expression correlates nicely with 
CCND1 expression at the same age (Fig 3.1) and provides possible justification for its 
requirement during postnatal retina development.  
 
 
Are G1 length and rate of cell cycle exit related?  
CCND1 is required in the G1 phase of RPCs to maintain proper cell cycle time 
and to prevent premature cell cycle exit. Both requirements seem to be linked to its role 
as a negative regulator of RB activity. Is it possible that these two aspects of RPC 
behavior, namely the time they spend in G1 and their terminal exit from the cell cycle at 
G1, are correlated or even causally related? That is, can an increase in G1 time result in 
an increased rate of cell cycle exit or vice versa? Although our studies (Chapter 2) show 
that both of these attributes are increased in the Ccnd1 null retina, a causal relationship 
between them was not addressed. 
Inhibition of Ccnd1 or CcnE in progenitor cells during cortical development led to 
longer cell cycle times; additionally, it also led to a larger proportion of these progenitors 
leaving the cell cycle to enhance neurogenesis (Lange et al., 2009; Pilaz et al., 2009). 
Conversely, siRNA-mediated knockdown of either Ccnd1, Ccnd1-Cdk4 complex, or 
CcnE, led to lengthening of G1and depletion of cortical progenitors through enhanced 
cell cycle exit, thus causing increased neurogenesis. This phenotype is similar to the 
Ccnd1 null retina (Lange et al., 2009; Pilaz et al., 2009) (Chapter 2). Further, treatment of 
whole mouse embryos in culture with olomoucine (a CDK inhibitor) lengthened the cell 
cycle and led to premature neurogenesis (Calegari and Huttner, 2003). In general, it 
appears that ‘anti-proliferative’ genes or growth factors that slow the cell cycle increase 
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neurogenesis. Conversely, when such genes are deleted or when growth factors that 
accelerate the cell cycle are applied, neurogenesis is reduced (Salomoni and Calegari, 
2010).  
These observations led to the formation of the cell cycle length hypothesis. This 
hypothesis predicts that G1 length itself is a determinant of proliferation versus 
neurogenesis/differentiation decisions (Calegari and Huttner, 2003). It proposes that any 
increase in G1 time opens a longer time window for a cell fate determinant to act and 
influence the cell to adopt a different available fate (Calegari and Huttner, 2003; 
Salomoni and Calegari, 2010). Indeed, as seen by the examples cited earlier, a positive 
correlation between increased G1 length (cell cycle time) and differentiation is also seen 
in other stem/progenitor cell systems beside neuroepithelial cells. ESCs usually divide 
rapidly with a very short G1 phase, but with lineage restriction or differentiation, their G1 
and overall cell cycle time is increased (Fluckiger et al., 2006; Neganova and Lako, 
2008). Even in a rat model of ischemia or stroke, where adult neurogenesis is promoted, 
the rapidly dividing proliferating cells initially have a short G1 and low rate of 
neurogenesis. Later, G1 lengthens, neurogenesis levels climb and eventually reaches pre-
stroke normal levels (Zhang et al., 2008; Zhang et al., 2006). 
It is important to remember that G1 ‘time’ is probably a reflection of molecular 
interaction kinetics between positive and negative regulators of G1 progression like 
CCND1 and RB. It would require further investigation to prove whether the ‘cell cycle 
length hypothesis’ holds true in the retina. In fact, a couple of studies in the retina suggest 
the opposite. In the zebrafish mutant disarrayed, cell cycle time is greatly increased, but 
neurogenesis is decreased (Baye and Link, 2007a). In some ways, the disarrayed mutant 
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is similar to the Vsx2 mutant mouse: they both have hypocellular retinas, lengthened cell 
cycle time of RPCs, and reduced or unchanged rate of neurogenesis (Levine E.M, 
unpublished data). Therefore, it is possible that in the developing retina, the ‘cell cycle 
time hypothesis’ does not hold true.  
However, both the disarrayed and Vsx2 mutant RPCs experience prodigious 
increases in cell cycle time. In the disarrayed mutant, G1 is increased almost one-and-
one-half fold, S-phase is increased almost two fold, and overall cell cycle is increased 
more than two fold (Baye and Link, 2007a). In the Vsx2 mutant, the increase in cell cycle 
time is equally large, if not more (Levine E. M; unpublished data). In comparison, the 
overall increase in cell cycle time is a modest ~50% in Ccnd1 null RPCs (Fig 2.2). It can 
be argued that cell cycle rates in disarrayed or Vsx2 mutant retinas are well beyond 
normal levels during development. Therefore, a wild type RPC at P0 may have cell cycle 
times that are close to what a Ccnd1 null RPC had at E14.5 (Fig 2.2). However, wild type 
RPCs probably never experiences cell cycle times comparable to the disarrayed or the 
Vsx2 mutant. In fact, the shortest RPC cell cycle in the disarrayed mutant (> 16 hours) is 
longer than the longest RPC cell cycle in the wild type (14.8 hours) (Baye and Link, 
2007a). The possibility that the ‘cell cycle length’ hypothesis in the retina only holds 
when cell cycle times are within the usual developmental range cannot be formally ruled 
out without further studies. 
 
 
CCND1 and cell fate specification in the retina 
In the absence of CCND1, changes in the production and number of retinal 
precursor cells indicate a cellular fate switch phenomenon. So for instance, the excess of 
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ganglion cell production observed in the early mutant retina could very well be at the 
expense of cones or PTF1A expressing horizontal/amacrine cell precursors. In Chapter 2, 
we propose a model where such apparent fate changes could be an indirect effect of 
mistimed cell cycle exit in the absence of CCND1 (Fig 2.10). Could CCND1 have a 
direct effect on cell fate? There is ample evidence that CCND1 has cell cycle independent 
or CDK binding-independent roles. Among other things, CCND1 can repress the 
transcription of pro-neural or pro-differentiation genes (Coqueret, 2002; Fu et al., 2004).  
So for instance, CCND1-CDK complexes can inhibit skeletal muscle differentiation by 
both RB-dependent and independent pathways (Skapek et al., 1996). In epithelial cells of 
the small intestine, CCND1 acts in the proliferative crypt compartment to 
transcriptionally inhibit the BHLH factor BETA2/NEUROD in association with the co-
activator p300. NEUROD promoted cell cycle withdrawal of epithelial cells to form the 
differentiated villus compartment (Naya et al., 1995; Ratineau et al., 2002). In the retina, 
NEUROD is important for amacrine and photoreceptor cell fate specification (Ohsawa 
and Kageyama, 2008). Modest levels of NeuroD mRNA and protein upregulation were 
observed in Ccnd1-/- retinas (Bienvenu et al., 2010; G.D and E.M.L unpublished 
observations). Whereas NeuroD overexpression favored amacrine cell production 
(Morrow et al., 1999), amacrine cells were selectively reduced in Ccnd1 mutant retinas 
(Fig 2.7). However, in both the cases, rod photoreceptor production was enhanced 
(Morrow et al., 1999). Therefore, it would require careful analysis to determine whether 
NEUROD actually plays a significant role as a transcriptional target of CCND1 during 




Restricted cellular lineages in the retina 
Studies outlined in Chapter 2 convincingly demonstrate that the early increase in 
ganglion cell production is due to a relative increase in cell cycle exit. However, the loss 
of other early-born cell types in Ccnd1 null retinas is harder to explain. It may not be due 
to increased apoptosis in the mutant retina (Fig 2.12). Two different, not mutually 
exclusive, possibilities involving roles for CCND1 in cell cycle exit timing and in cell 
fate was offered (Fig 2.10 and previous section). A third possibility is that horizontal cells 
and some amacrine cell types arise from lineage-restricted, biased RPCs that are 
prematurely depleted in the mutant. The situation would be analogous to the loss of 
cerebellar granule cells or cortical PV+, GABAergic interneurons in Ccnd1-/- or Ccnd2-/- 
mice (Ciemerych et al., 2002; Glickstein et al., 2007; Huard et al., 1999; Pogoriler et al., 
2006). In this scenario, a subset of RPCs with limited cell division and cell fate potential 
co-exist with the early multipotential RPC population. When these lineage-restricted 
RPCs prematurely exit the cell cycle, the cell types they were biased to produce are 
depleted. Further, the complementary branches of multipotential RPC population fail to 
compensate for the lost cell types.  
Existence of such biased or lineage –restricted RPC population, associated with 
horizontal and amacrine cells, has been shown in multiple species (Alexiades and Cepko, 
1997; Godinho et al., 2007; Li et al., 2004; Moody et al., 2000; Rompani and Cepko, 
2008). Other studies have shown the presence of rod-committed RPCs that are biased to 
produce rod photoreceptors (Cayouette et al., 2003; Cohen et al., 2010; Turner and Cepko, 





 This work has led to some important questions about the basic mechanisms of 
retina development and the role of Ccnd1 in retinal histogenesis. Some potential future 
directions are briefly discussed below. 
Not much is known about cell cycle dynamics during retina development. A 
relatively simple way to set out in this direction would be to investigate cell cycle 
kinetics in pre-neurogenic RPCs. Existing literature indicates that these cells express 
CCND1 (Das et al., 2009) (Fig 1.1) but not RB factors (Spencer et al., 2005). A part of 
our current hypothesis is that CCND1 is only required in RB expressing RPCs to 
maintain cell cycle time. Therefore, the prediction would be that the cell cycle time of 
these RPCs should not change upon deletion of CCND1.  
After the onset of neurogenesis, not all RPCs express RB proteins (Donovan et al., 
2006; Spencer et al., 2005; Zhang et al., 2004). Another part of our current hypothesis is 
that RB expression also defines a subset of CCND1-dependent RPCs that exit the cell 
cycle prematurely in the absence of Ccnd1.  
Put together, we think that RB expression defines sets of RPCs that rely on 
CCND1 for proper regulation of cell cycle time and cell cycle exit. Our hypothesis posits 
that at least two major populations of RPCs exist in the developing retina with significant 
differences in G1/cell cycle time, based on the status of RB expression. We had also 
proposed in Chapter 3 (Fig 3.7) that the set of RPCs that depend on CCND1 for cell cycle 
time regulation is larger than the set of RPCs that require CCND1 to prevent exit. It is 
possible that besides RB expression, which is common to both sets, expression and 
utilization of other factors further define these subsets. Therefore, CCND1 may be 
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required more globally for cell cycle time regulation, but RPCs can utilize other 
molecules besides CCND1 to regulate cell cycle exit ((Trimarchi et al., 2008). This 
explains why some RPCs may not exit from the cell cycle prematurely, but may have 
longer cell cycle times without CCND1. 
Live time-lapse imaging in zebrafish retina revealed a large range of cell cycle 
times of 4 hours to over 11 hours (Baye and Link, 2007b). Likewise, live imaging of the 
mouse retina will be a direct approach to analyze cell cycle times during development. 
Conventional modes of cell cycle measurements in fixed tissue using labeled nucleotide 
analogs may also be able to identify discrete sets of RPCs based on their cell cycle time. 
Analysis of appropriate genetic models of cell cycle regulators using the above-stated 
approaches would provide valuable insights on the workings of progenitor cells in the 
retina.  
What are the molecular mechanisms of CCND1’s function in the retina? A recent 
study used a molecularly tagged version of CCND1 to catalog its binding partners and 
transcriptional targets in the neonatal mouse retina (Bienvenu et al., 2010). Notch1 was a 
prominent transcriptional target validated in this study. Its transcript and proteins levels 
were reduced in the Ccnd1-/- mutant (Bienvenu et al., 2010). Previous studies showed that 
the Notch1 deletion phenotype in the retina was somewhat similar to the Ccnd1-/- retinal 
phenotype, although the former was much severe than the latter (Das et al., 2009; Jadhav 
et al., 2006). This indicates that CCND1 mediated regulation of Notch 1 is somewhat 
limited. It is probably restricted to a subset of ‘exit-prone’ RPCs, similar to the CCND1-
dependent set described earlier. Additionally, there is plenty of evidence in the literature 
placing Notch signaling upstream of Ccnd1 in a wide variety of scenarios ranging from 
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cancer to development (Campa et al., 2008; Cohen et al., 2009; Ronchini and Capobianco, 
2001; Rowan et al., 2008; Tanaka et al., 2009). Therefore, the possibility remains that 
Notch signaling acts upstream of Ccnd1 in a cellular context-dependent manner. 
Understanding of the molecular mechanisms of CCND1 function would require 
validation of putative binding and transcriptional targets in defined retinal cell 
populations.  
Does CCND1 affect symmetry of division of RPCs? Symmetry of cell division in 
the retina may play a major role in cell fate and overall histogenesis in the retina (Malicki, 
2004). It is not difficult to anticipate a change in symmetry of division without CCND1. 
Premature cell cycle exit implies that a cell that was destined to stay in the cell cycle now 
withdraws from it. In the vast majority of cases, this invariably results in a change of 
division symmetry. A division that would normally produce an RPC and a precursor, in 
the absence of CCND1, would produce two precursors due to premature cell cycle exit. A 
recent study combining live imaging of cultured rat RPCs with computational prediction 
algorithms was able to predict with high accuracy (> 80%) the cellular outcome of RPC 
division (Cohen et al., 2010). The algorithm ‘learned’ to associate various visually 
tracked dynamic characteristics of the pre-mitotic RPC, -like cell shape, size and 
displacement- with the outcome of division. Ultimately, the algorithm was able to predict 
the progeny of a live RPC in culture before it divided (Cohen et al., 2010). A similar 
study with mutant RPCs, lacking CCND1 or other factors, would be able to directly 
observed progenitor behavior in vitro, or in the future, in vivo.  
Finally, and not of the least importance, would be to study the effect of CCND1 
loss in specific retinal lineages. Unfortunately, some of the tools required for such 
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experiments are not available yet. Foremost amongst them is a conditional mouse allele 
of Ccnd1 that can facilitate deletion of Ccnd1, from specific retinal cell populations by 
crossing with retinal lineage specific Cre mouse lines (Schweers- Dyer 2005). With a 
conditional deletion, allele of Ccnd1 specific questions regarding its role in retinal 
development can be addressed. This would include temporal deletion of CCND1 during 
mouse development to study its late role in retina development and degeneration (Ma et 
al., 1998). Ccnd1-/- retinas have defects in retinal vasculature (G.D and E.M.L, 
unpublished observations). Conditional deletion of Ccnd1 from endothelial cells or in the 




Studies in this dissertation were aimed at elucidating the role of D-cyclins in 
retinal progenitor cell proliferation and neuron production. Further, the goal was to 
understand how D-cyclins influence these processes by regulation of cell cycle 
parameters like the duration of RPC cell cycle or the timing of exit of RPCs from the cell 
cycle. The two major functions for CCND1 that emerges from these studies are to 
prevent inappropriate increase in RPC cell cycle time and to prevent RPCs from 
prematurely exiting the cell cycle. CCND1 also regulates the composition of retinal cell 
populations by altering their output during histogenesis.  
These studies were important because they offered insights into mechanisms of 
retinal development and highlighted the importance of cell cycle regulation during this 
process. Further, they shed light on fundamental cell cycle properties of dividing 
stem/progenitor cells. Future studies addressing direct mechanistic connections between 
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cell cycle kinetics and retinal proliferation/neurogenesis would be both critical and 
interesting. It may provide clues to producing a desired complement of differentiated 
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